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Interdisciplinary Studies

Examining the Relationship of Physical Activity with Inflammation and
Cardiovascular Disease Risk
Steven Fehrer, Chair
Cardiovascular disease (CVD) accounts for 37.1 percent of all deaths in the
United States. Physical activity is inversely related to both CV event risk and to
many of the individual CVD risk factors. The inverse relationship between
physical activity and CVD risk is well established. However, much dispute
remains about the optimal physical activity intensity and duration related to health
benefits and to lower CVD risk. The ability to objectively measure intensity and
duration may clarify the inverse relationship between physical activity and CVD.
The purpose of this collection of studies was to explore the association of
physical activity with CVD and attempt to identify some specifics of this complex
relationship. Results: In healthy sedentary individuals aged 31 to 66, 2 different
activity accumulation programs were effective in increasing physical activity and
resulted in improved fitness and blood glucose. However, the improvement in
activity was not of sufficient intensity to provide changes in multiple heart disease
risk factors or inflammation. In a cross-section sample of males and females
aged 18 to 65, both active and sedentary, the relationship between physical
activity and CVD risk varied by age group. The inverse relationship between
physical activity and CVD risk was confirmed. However, reaching higher intensity
levels for 1 minute periods at least 5 minutes a day appears to be better related
to lower risk of CVD than longer durations of moderate or vigorous activity per
day, particularly in younger individuals. In a sample of stroke survivors aged 50
to 72, 3 out of 6 of the modifiable risk factors for CVD were present. In these
stroke survivors, physical activity intensity and duration were well below current
recommendations and insufficient for CVD risk reduction. Conclusions:
Accumulating activity can be effective in meeting physical activity
recommendations however both duration and intensity requirements must be
achieved. Combinations of higher intensities for shorter durations may also be
effective in CVD risk reduction.
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GLOSSARY

6 minute walk. A submaximal functional exercise test that correlates with
maximal oxygen uptake
accelerometer. A motion sensor device used to objectively measure physical
activity by continuously recording multidirectional movement
acidosis. An increased acidity or increased hydrogen ion (H+) concentration in
the bloodstream due to increased production of H+ by the body
Actical. Brand name of accelerometer made by Mini Mitter and Respironics®
Active Living Everyday® (ALED). An educational program designed to promote
increasing physical activity through changes in lifestyle
activity monitor. A term used to generically describe devices that measure
physical activity like an accelerometer
acute phase response. A body defense that occurs during acute illnesses
involving increased production of blood proteins termed acute phase
proteins like C-reactive protein that are produced by cells in the liver that
promote inflammation
acute phase protein. A cytokine protein whose plasma concentration increases
by 25% or more during an acute inflammatory response
aerobic fitness. The ability of the circulatory and respiratory systems to supply
oxygen to skeletal muscles during sustained physical activity. The
quantification of the ability to sustain work for prolonged periods
anaerobic metabolism. Energy utilization (catabolism) that is not dependent on
oxygen
angiography. The radiographic visualization of the blood vessels after injection
of a radiopaque substance
assay. Analysis of a substance to determine the presence, absence, or quantity
of one or more components
atherosclerosis. A progressive disease process characterized by an
accumulation of abnormal fatty deposits (plaque) in the inner layer of the
arteries (endothelium)
vii

basal metabolic rate. The minimal level of energy required to sustain vital
functions in the waking state
body mass index (BMI). A commonly used measure of body fatness calculated
by dividing the weight (kilograms) of an individual by their height (meters)
squared
Borg rating of perceived exertion (RPE). A measurement scale used to obtain
quantitative identification of the feeling of fatigue that is highly correlated
with heart rate
calorimetry. A non-invasive measurement of energy expenditure using oxygen
consumption
cardioprotective. Anything that reduces risk or problems related to the heart
cardiorespiratory fitness. The ability of the circulatory and respiratory systems
to supply oxygen to skeletal muscles during sustained physical activity
cardiovascular disease (CVD). A class of diseases that involve the heart or
blood vessels usually used to refer to those related to atherosclerosis
cardiovascular events. An incident related to or caused by cardiovascular
disease (atherosclerosis) causing temporary or permanent blockage of an
artery and resulting in damage to an organ (heart, brain) supplied by the
artery
cell adhesion molecules. Molecules that regulate the binding of a cell to
another cell or to a surface or matrix
cerebrovascular accident (CVA). Also known as stroke. A loss of a portion of
brain function due to an interruption in the blood supply to part of the brain
coronary heart disease (CHD). The result of the accumulation of atherosclerotic
plaques within the walls of the arteries that supply the heart
C-reactive protein (CRP). An acute phase protein (cytokine) produced by the
liver found in the plasma and used as a marker of systemic inflammation
cytokines. Small secreted proteins which mediate and regulate immunity and
inflammation
cytotoxic. Any agent or process that kills cells
viii

diabetes mellitus. A metabolic disorder characterized by hyperglycemia (high
blood sugar) resulting from low levels of insulin or resistance to the effects
of insulin
doubly-labeled water. An isotope-based method of estimating total daily energy
expenditure in free-living conditions
dyslipidemia. A disorder of lipoprotein metabolism, that may be manifested by
elevation of the total cholesterol, low-density lipoprotein cholesterol and
the triglyceride concentrations, and a decrease in the high-density
lipoprotein (HDL) cholesterol concentration in the blood
electrocardiogram. A recording of the electrical activity of the heart
endothelium. A layer of flat cells lining the closed internal spaces of the body
such as the inside of blood vessels
ergometry. The process of measuring work performed during exercise
erythrocyte sedimentation rate (ESR). A blood test that is used to monitor
inflammation that is measured by recording the rate at which red blood
cells sediment in a tube of normal saline over time
excess CO2. The carbon dioxide exhaled due to the buffering of hydrogen ions
during exercise above the ventilatory or anaerobic threshold
fatty streaks. Lesions in the blood vessels caused by an elevated local content
of membrane bound cholesterol and fats that represent the earliest visible
stage of atherosclerosis
fibrinogen. An acute phase protein from which a normal blood clot may
eventually be generated
foam cells. Particular cells found in the blood vessel endothelium derived from
both macrophages (white blood cells) and smooth muscle cells which
have accumulated and oxidized low density lipoproteins. Develop after
fatty streaks and present in intermediate and advanced stages of
atherosclerosis
Framingham risk score. A risk calculation based on the Framingham heart
study that evaluates a person's risk of developing coronary heart disease
in the next 10 years

ix

Friedwald equation. The most common method used for indirectly measuring a
cholesterol component such as low density lipoprotein when the other
major levels are already known
Glycosylated hemoglobin (HbA1c). A blood test that provides an average of
blood glucose measurements over a 2-3 month period by measuring the
amount of sugar attached or combined with hemoglobin
Hepatic. Having to do with the liver
high density lipoprotein (HDL). A molecule made up of combinations of lipids
and proteins that transports cholesterol to the liver. The higher the HDL
cholesterol level, the lower the risk of coronary artery disease
hypertension. High blood pressure
Ig-G (immunoglobulin-G). The most abundant antibodies circulating in the
blood. Involved in inflammation and the immune response
IL-1 (interleukin-1). A pro-inflammatory cytokine involved in the immune
response that increases the expression of cellular adhesion factors
IL-6 (interleukin-6). A pro-inflammatory cytokine secreted by T cells and
macrophages to stimulate and mediate the acute phase response
inflammatory markers. Proteins found in the blood plasma that can be used to
indicate an inflammatory process is taking place (C-reactive protein and
fibrinogen)
insulin sensitivity. The amount of responsiveness of the cell to insulin when it
binds to cell receptors (to facilitate glucose uptake). Sensitivity is
decreased when exposed to high insulin levels over long time periods and
is the precursor of type 2 diabetes mellitus
kilocalorie (kcal). A unit of measurement of the amount of energy expended or
consumed
lactate. The byproduct of energy expenditure (glycolysis) during intense
exercise, when aerobic metabolism cannot produce ATP quickly enough
to supply the demands of the muscle
lactate threshold. Represents the highest steady-state exercising intensity that
can be maintained for prolonged periods of time (anaerobic threshold).
Above this point, lactate production exceeds clearance
x

low density lipoprotein (LDL). A molecule made up of combinations of lipids
and proteins that carries cholesterol from the liver to other cells and
tissues
lupus erythamatosis. An autoimmune inflammatory disease of the connective
tissues
macrophages. A type of white blood cell that ingests foreign material and is a
key player in the immune response
metabolic equivalent (MET). A ratio comparing energy expenditure in the
resting state to metabolic rate while performing some task. Commonly
used in the context of aerobic exercise to gauge the intensity of the
workout
metabolic syndrome. A collection of commonly clustered conditions or risk
factors that increase your chance of developing heart disease, stroke, and
diabetes
minute ventilation. The volume of air breathed each minute. A measurement
used when measuring oxygen consumption to calculate energy
expenditure
moderate intensity. A relative measure of difficulty of physical activity, defined
as physical activity between 3 and 6 METs
modified v-slope. A method of visually determining ventilatory threshold that
plots the minute production of carbon dioxide (VCO2) versus the minute
utilization of oxygen (VO2)
pedometer. A portable device which counts each step a person takes that is
often used as a monitor to promote increases in physical activity
physical activity (PA). Any bodily movement, planned or unplanned, produced
by skeletal muscles that results in energy expenditure
physical fitness. A set of attributes that a person has that relate to the ability to
perform physical activity. Cardiorespiratory fitness is a type of fitness
related to the ability to perform aerobic (endurance) activities
plaques. An accumulation and swelling in artery walls that is made up of cells, or
cell debris, that contain cholesterol, calcium and other tissue
characterizing the atherosclerotic disease process
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Reebok 1-mile walk. A validated field test that allows estimation of VO2max
using heart rate and one-mile walk time
respiratory exchange ratio (RER). The ratio of carbon dioxide produced to
oxygen consumed. Used in indirect calorimetry testing of energy
expenditure
rheumatoid arthritis. A chronic, inflammatory autoimmune disorder that causes
the immune system to attack the joints
sedentary. Activity level defined as not meeting the guidelines of 30 minutes of
moderate level activity most days a week
serum. The liquid component of blood, in which the blood cells are suspended
stages of change. Also known as the transtheoretical model is a model that
describes how changes in behavior proceed. It recognizes that a change
in behavior occurs gradually and at an individualized rate
stroke. A loss of a portion of brain function due to an interruption in the blood
supply to part of the brain
thrombosis. The obstruction of an artery or vein by a blood clot
timed up and go (TUG). A validated test that combines balance, coordination
and function most commonly used to assess fall risk. It includes a number
of tasks such as standing from a seating position, walking, turning,
stopping, and sitting down
TNF-alpha (Tumor necrosis factor-alpha). A cytokine involved in systemic
inflammation that stimulates the acute phase response
transtheoretical model. A model that describes how changes in behavior
proceed. It recognizes that a change in behavior occurs gradually and at
an individualized rate
type 2 diabetes mellitus. A metabolic disorder characterized by hyperglycemia
(high blood sugar) resulting from resistance to the effects of insulin
ventilatory equivalent (Ve). Term used to describe minute ventilation during
breathing
ventilatory equivalent method. A means of visually determining ventilatory
threshold by plotting the ratio of Ve to oxygen consumption (Ve/VO2) over
the ratio of Ve to carbon dioxide expiration (Ve/VCO2)
xii

ventilatory threshold. Represents the highest steady-state exercising intensity
that can be maintained for prolonged periods of time. Indicated by the
point where ventilation increases disproportionately to oxygen
consumption
vigorous intensity. A relative measure of difficulty of physical activity, defined
as physical activity above 6 METs
VO2max. The maximal capacity of the cardiovascular system to provide oxygen
to muscle cells during sustained exercise generally measured in a graded
exercise test. Reached when oxygen consumption plateaus despite
increases in workload
VO2peak. The maximum oxygen capacity attained in an incremental exercise
test if VO2max was not reached
Westergren method. Most common procedure for testing erythrocyte
sedimentation rate
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INTRODUCTION

Cardiovascular disease (CVD) is the leading cause of death in the United
States.1, 2 Risk factors have been established for CVD, however cardiovascular
(CV) events like myocardial infarction and stroke often occur when CVD risk
factor levels are within normal limits. Routine physical activity decreases CVD3, 4
and its risk factors5-9 and improves health.2 Physical activity is inversely related
to both CV event risk and to many of the individual CVD risk factors
(hypertension, dyslipidemia, diabetes mellitus, obesity).2
Despite the overwhelming evidence of the benefits of physical activity,
more than 60% of adults in the United States are not regularly physically active
and 25% are not active at all.2 Current physical activity recommendations are to
accumulate 30 minutes of moderate activity most days of the week. These
recommendations may be met through one continuous bout of exercise or
through accumulation of several shorter bouts.2 Some programs encourage
accumulation of physical activity throughout the day using pedometers to monitor
physical activity. It is unclear if the intensity and duration of physical activity
attained in these accumulated physical activity programs is sufficient to improve
CVD risk factors.
The inverse relationship between physical activity and CV risk is well
established however much dispute remains about the optimal intensity and
duration of physical activity needed to induce health benefits and to lower CV
risk. Because it is very difficult to obtain accurate information on habitual daily
1

activity without disrupting free living, physical activity recommendations are broad
and the specifics of the relationship between physical activity and CV risk remain
uncertain. Physical activity recommendations have evolved from 20 minutes of
vigorous activity 3 days per week to at least 30 minutes of moderate activity most
days of the week.2 These recommendations are based on epidemiological
evidence using self-reported physical activity and cardiorespiratory fitness
(VO2max). Self-report is a subjective assessment of physical activity and error
rates range from 35 to 50 percent.10, 11 Although findings using cardiorespiratory
physical fitness (VO2max) are more consistent than those using self-reported
physical activity,2 cardiorespiratory fitness does not provide specific information
on physical activity intensity and duration during free living. If the intensity and
duration of physical activity best related to CV risk could be identified, perhaps
public physical activity recommendations could be improved.
In individuals with physical impairments, the relationship between physical
activity and CVD risk may differ from the general population. Residual
neurological impairments from stroke decrease energy efficiency and increase
energy cost of movement. As a result a higher intensity of physical activity is
required for mobility and routine daily activities. If stroke survivors work harder
than individuals without impairment to perform the same task, then fitness levels
should be higher in stroke survivors unless other parameters of physical activity
differ. Measurement of habitual physical activity intensity and duration would
assist in better defining the relationship between physical activity and CVD risk in
these individuals.
2

Cardiovascular events like myocardial infarction and stroke often occur
when CVD risk factor levels are within normal limits. Researchers have
suggested the use of C-reactive protein (CRP) levels to improve the detection of
CV risk and increase the prediction of CV events.12 Physical activity may also be
inversely related to baseline levels of CRP.13 The short term effects of exercise
on CRP levels have been investigated however the relationship between habitual
physical activity and CRP has yet to be explored.
By investigating the relationship between physical activity and CVD risk
factors including CRP, additional information may be obtained on how to
decrease CVD risk prior to a CV event and advise individuals on appropriate
activity programs for cardiovascular health. The purpose of this collection of
studies is to explore the association between CVD and physical activity and
attempt to identify some specifics of this complex relationship.
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CHAPTER 1
REVIEW OF LITERATURE

Cardiovascular Disease
Cardiovascular disease (CVD) is the number one cause of death in the
United States and other westernized societies and its incidence continues to
rise.1, 2 By the year 2020, cardiovascular disease will be the leading cause of
mortality in the world.1 Cardiovascular disease is comprised of several different
diseases all caused by atherosclerosis. Atherosclerosis of the heart is coronary
heart disease (CHD), of the brain is ischemic cerebrovascular disease (CVA or
stroke) and of the extremities is peripheral vascular disease (PVD).
Atherosclerosis is a progressive disease that is caused by an accumulation of
plaque along the blood vessels walls (endothelium). Risk factors are common in
children and persist into adulthood.14 Plaque buildup begins in childhood with
fatty streaks characteristic of atherosclerosis detected as early as adolescence.14
Much research has been done into what causes and predisposes
individuals to developing cardiovascular disease. The Surgeon General’s report
on the importance of physical activity for health and prevention of disease
identified 8 risk factors for cardiovascular disease.2 They include age greater
than 45 for males and greater than 55 for females, family history of CVD, high
blood pressure (hypertension), diabetes mellitus, smoking, dyslipidemia
(cholesterol imbalance), obesity and lack of physical activity. Only two of these
factors are unchangeable, age and family history. The remaining six are
4

commonly seen together and are modifiable through lifestyle changes. The
modifiable risk factors high cholesterol, smoking, high blood pressure, diabetes
mellitus, obesity and physical inactivity will be briefly discussed below.
Hypertension
It is commonly accepted knowledge that high blood pressure is a risk
factor for CVD. The Framingham study revealed the importance of systolic blood
pressure on the risk of CVD.15 Isolated systolic hypertension ( > 160mmHg) was
found to be independently predictive of CVD.16 Lowering diastolic blood pressure
by 5 mm/Hg lowers the risk of stroke by 34% and CVD by 21% according to a
review of the literature by MacMahon et al.17 Normal levels of blood pressure are
systolic less than 120 mmHg and diastolic less than 80 mmHg.
Smoking
Smoking is a major cause of CVD2 and is included in major risk
assessments such as the Framingham for CVD and stroke.18 The relative risk
(RR) of CVD for smoking 1 to 5 cigarettes per day was calculated to be 2.47
(95% confidence interval (CI), 1.12 - 5.45) and for smoking 1 to 14 cigarettes per
day was 3.12 compared to that of non-smoker (RR = 1.0).19, 20 In the Nurses
Health Study, a strong dose response relationship was found between risk of
CVD and the number of cigarettes smoked per day.21 The Surgeon General
recommends total cessation of smoking for optimal health.20
Dyslipidemia
Dyslipidemia is defined as having elevated levels of total cholesterol (TC)
and low density lipoprotein cholesterol (LDL) and depressed levels of high
5

density lipoprotein cholesterol (HDL). Normal levels of total cholesterol are less
than 200 mg/dl, optimal LDL cholesterol levels are less than 100 mg/dl with less
than 130 mg/dl considered normal and for HDL cholesterol levels greater than 40
mg/dl are considered normal.22 Total cholesterol, LDL cholesterol and HDL
cholesterol are well established as strong independent predictors of CVD.15, 22 A
meta-analysis by the National Heart, Lung and Blood Institute disclosed that
there is a 2 to 4 times greater CVD risk in individuals with total cholesterol
greater that 240 mg/dl than those with levels less than 200 mg/dl.23 It was
ascertained in the Framingham Study,15 and is now well established in the
literature, that levels of LDL cholesterol are positively associated with the risk of
CVD.24 The Asia Pacific Cohort Studies Collaboration compared quartiles of LDL
cholesterol levels and found that the highest LDL cholesterol level had a relative
risk for CVD of 1.55 (95% CI, 1.10 - 2.18) versus the lowest LDL cholesterol
level.24
Levels of HDL cholesterol are inversely related to CVD incidence. Low
concentrations of HDL cholesterol (25 mg/dl) were associated with high risk of
CVD regardless of LDL cholesterol levels.25 The Israeli Ischemic Heart Disease
Study compared HDL cholesterol levels to risk of ischemic stroke mortality.26
Men in the lowest HDL cholesterol tertile had a 1.32 risk of mortality from stroke
than those in the highest tertile of HDL cholesterol (95% CI, 0.95 to 1.83).
Increasing HDL cholesterol levels by 1 mg/dl reduces CVD risk by 3% in women
and 2% in men.25

6

Diabetes Mellitus
Cardiovascular disease is the cause of death in 65% of patients with Type
2 diabetes mellitus.18 Type 2 diabetes is characterized by insulin resistance and
as a result, persistently high blood glucose levels (hyperglycemia). People with
diabetes have a two to four times greater risk of developing CVD than those with
normal fasting glucose levels.27 Preceding the onset of type 2 diabetes by years
is a common clustering of risk factors for CVD known as metabolic syndrome.
Metabolic syndrome is characterized by hyperglycemia, dyslipidemia, obesity,
and hypertension among other conditions.28 The high number of CVD risk
factors present in individuals with either metabolic syndrome or type 2 diabetes
increases the likelihood of a CVD event. Normal fasting blood sugar values are
less than 100 mg/dl or hemoglobin A1C levels of 4 to 6 percent.29 The HbA1c
test, which measures the percentage of red blood cells with glucose bound to the
hemoglobin, is considered the most objective and reliable measure of long term
blood sugar levels.30, 31
Obesity
Obesity is related to increased insulin resistance (the precursor of type 2
diabetes mellitus), blood pressure and LDL cholesterol levels.27, 28, 32 A clinical
measurement of total obesity is body mass index (BMI) and is calculated by
obtaining an individual’s weight in kilograms and dividing it by the square of the
height in meters. Normal levels of BMI are considered to be less than 25 kg/m2,
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obese greater than 30 kg/m2 and between 25 and 30 kg/m2 considered
overweight.33
Women with a BMI 23 to 25 kg/m2 had a 50% increase in CVD risk than
their lower weight counterparts. Men with BMI of 25 to 29 kg/m2 were 72% more
likely to develop CVD than men of normal weight.34, 35 Investigators in the first
National Health and Nutrition Examination Survey (NHANES) study observed the
relative risk for CVD of the obese group (BMI > 30 kg/m2) to be 1.28 versus
normal weight individuals (BMI < 25 kg/m2) risk of 1.00 (95% CI 1.10 - 1.49, p <
0.001).36 In general, as BMI increases, the relative risk of CVD increases.
Researchers have found a connection between visceral or central
abdominal obesity and risk of diseases such as CVD, the metabolic syndrome
and diabetes mellitus. The two most common assessments of abdominal obesity
include waist girth and waist to hip ratio. Two studies on Swedish men and
women conducted in 1984 established waist to hip ratio as a cardiovascular risk
factor.37, 38 Recommended waist to hip ratios are less than 0.88 in women and
less than 1.0 in men.33
Waist circumference alone, since it is one measure rather than two, has
also been advocated as a simple measure of abdominal obesity and has been
associated with CHD and CVD risk.39 In a 2003 study by Welborn et al. waist to
hip ratio predicted CVD and CHD mortality better than waist circumference alone
and both were better than BMI in both men and women but not all researchers
agree.40, 41 It is still a common practice to use BMI as a measure of obesity and
health risk. Most recently, Woo et al. found that the relationship of waist
8

circumference measurements with health risk is different in people over 70 years
old. The accuracy of prediction of CVD was reported to be similar to BMI.40
To evaluate obesity, the National Cholesterol Education Program (NCEP)
advises using a waist circumference greater than 102 cm (40 inches) in men and
greater than 88 cm (35 inches) in women however stricter guidelines have been
recently recommended.42, 43 Bray proposes stratified risk levels of waist
circumference using increments of ten centimeters to differentiate levels of very
low, low, high and very high.43 Less than 70 cm for women and less than 80 cm
for men is considered very low with 90 cm or more in women and 100 cm or
more in men considered high.43 To best assess total and abdominal adiposity as
well as risk of disease, researchers have suggested using both BMI and either
waist circumference or waist to hip ratio.43, 44
Sedentary Lifestyle
Lack of physical activity is an important risk factor in a number of chronic
diseases including diabetes mellitus, obesity and cardiovascular disease. Ten
years ago it was estimated that over 50% of the population of the United States
exercised for less than 20 minutes three times per week.45 From the 1996
Surgeon General’s report it was estimated that in the United States, more than
60% of adults are not regularly physically active, 25% are not active at all and
41% of women and 35% of men engage in no physical activity outside of work.2
In addition, nearly half of America’s youth are not vigorously active on a regular
basis with physical activity significantly declining during adolescence.2

9

Routine physical activity decreases atherosclerosis and cardiovascular
disease (CVD),4, 45 improves endothelial control,45 lowers blood pressure5-9
lowers body fat and obesity,5, 9 improves insulin sensitivity,5, 34, 46 improves total
cholesterol to HDL cholesterol ratios,5 raises HDL cholesterol levels,9 reduces
smoking frequency9 and decreases systemic inflammation.47-49 Other benefits
include decreased health care costs,2, 50, 51 improved mood, better quality of life
and decreased all cause mortality.52, 53
Physical activity is inversely related to CVD mortality risk.2, 54 A decrease
in total energy expenditure is associated with increased CVD risk regardless of
activity level and even after controlling for age and BMI.55 It is well established in
the literature that routine physical activity decreases the risk of atherosclerosis
and CVD for both older and younger adults2, 4 and even moderate levels of
activity can be cardioprotective.2 Currently, the amount of recommended physical
activity is 30 to 60 minutes of moderate level physical activity most if not all days
of the week.2, 56 These levels will be described in more detail in a later section.
Inflammation
Atherosclerosis is a primary cause of CVD. Studies in cell biology, on
animals, in clinical research and in epidemiology have suggested that
atherosclerotic lesions are caused by an inflammatory response.57 Ford et al
states that inflammation is of critical importance in the development of
cardiovascular disease and it occurs throughout the process of atherosclerosis.58
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Dyslipidemia
The inflammatory response in the artery wall is initiated and perpetuated
by high levels of LDL cholesterol in the bloodstream.1 These LDL cholesterol
particles get deposited within the walls of the endothelium and build up over time.
As atherosclerotic plaques build, the body attempts to process the deposits of
oxidized low density lipoprotein cholesterol within the plaques, causing an
inflammatory response by macrophages (a type of white blood cell) and
perpetuation of the problem. When the macrophages accumulate too much LDL
cholesterol, they burst becoming foam cells that remain within the endothelial
wall. This perpetuates the inflammatory response. The continuation of this
process results in a chronic, low grade inflammatory state.59, 60 Over the years,
these inflamed plaques can become unstable and prone to rupture or can
accumulate and narrow the blood vessel to a point that ischemia results in the
tissues supplied.
Atherosclerosis may be mediated by levels of HDL molecules in the
blood.1 The anti-atherogenic effects of HDL come from its reversal of cholesterol
deposition, anti-oxidative properties and anti-inflammatory role.1, 61, 62 High
density lipoproteins assist in the transport and removal of LDL cholesterol from
the bloodstream and the artery walls returning it to the liver for synthesis of other
substances.62 The presence of HDL cholesterol affects expression of endothelial
cell adhesion molecules,61 decreases the formation of oxidized LDL cholesterol
and probably even suppresses cytokine production (e.g. c-reactive protein) in the
liver.60 Low HDL cholesterol has been linked to higher risk of carotid artery
11

atherosclerosis, ischemic stroke and atherosclerotic progression.25 LDL
cholesterol concentration was positively associated and HDL cholesterol was
negatively associated with the extent of fatty streaks and raised lesions.63
Diabetes Mellitus
Those with type 2 diabetes and metabolic syndrome have accelerated
plaque development and advancement of atherosclerosis. Measurement of
atherosclerosis in patients undergoing angiography found that atherosclerosis
was significantly higher in subjects with diabetes than in those without diabetes.64
Aronson et al, observed the inflammatory marker C-reactive protein (CRP) to be
lowest among those with normal fasting glucose levels [high sensitivity CRP (hsCRP) 0.94 + 0.11, p = 0.018] and highest in individuals diagnosed with diabetes
(hs-CRP 1.11 + 0.13, p = 0.004).65 In addition, the investigators found mean
levels of CRP to increase with the number of metabolic syndrome components
present.65 Cross sectional findings confirm elevated inflammatory marker
concentrations among individuals who have diabetes.66
Smoking
Smoking is known to accelerate atherosclerotic plaque development from
the time of earliest detection to the most advanced stages of atherosclerosis.67
Smoking was associated with more extensive fatty streaks and raised lesions in
the abdominal aorta than not smoking.63 Grundy et al suggest that cigarette
smoking promotes rupture and thrombosis of atherosclerotic plaques by
destabilizing them.67 It is believed that the chemical toxins in cigarette smoke
irritate the endothelial lining accelerating the inflammatory response. Smoking
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cessation lowers the risk of atherosclerotic thrombosis by one half after one
year.68
Hypertension
Inflammation is also thought to play a role in the development of hypertension or
high blood pressure.69 The level of the inflammatory marker CRP was
associated with increased risk of hypertension in the Women’s Health Study.69
As atherosclerotic plaques accumulate within the blood vessel walls, the arteries
are believed to become less compliant and unable to adjust to differing blood
flow pressures and volumes. The presence of atherosclerotic inflammation in the
vessels walls may reduce nitric oxide production in the endothelial cells further
exacerbating the situation by causing vasoconstriction and increasing blood
pressure further.70
Obesity
Obesity, blood pressure, diabetes and smoking were all positively
associated with levels of inflammation as measured by CRP.57 There is a strong
association of the inflammatory marker CRP with components of the metabolic
syndrome, particularly obesity (r = 0.36, p < 0.0001).65 Abdominal fat often called
central obesity, is suggested as a key regulatory site for the inflammatory
process.65, 71 In cross sectional studies, elevation of CRP was found among
individuals who are obese.66 A high negative correlation between weight loss and
inflammation was observed by Heilbronn et al and by Tchernof et al in two
separate studies of healthy obese women.71, 72
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Inflammation and Cardiovascular Disease
Because the development of atherosclerosis is undetectable without
invasive procedures, scientists have searched for indicators of impending
cardiovascular events. Many measures including LDL cholesterol and the ratio of
total cholesterol (TC) to high density lipoprotein (HDL) have been used to monitor
the potential for an atherosclerotic ischemic event. However, these measures
have not proven predictive. For example, elevated LDL cholesterol levels are
present in only 50% of individuals who experience a cardiovascular event.73, 74
Seventy seven percent of first cardiovascular events occurred in women with
LDL cholesterol levels below 160 mg/dl and 46% occurred with levels below 130
mg/dl.73 Clearly, another measure is needed to assist in predicting risk of
cardiovascular morbidity.
Researchers have suggested that low grade inflammation can predict
increased risk of cardiovascular events but a causal connection has not been
determined. Since atherosclerosis is an inflammatory process, a marker of
inflammation is a logical choice to monitor progression. Almost every phase of
the atherosclerotic disease process involves acute phase reactants that are
characteristic of the inflammatory process.75 Serum markers of inflammation
have the potential to directly or indirectly monitor atherosclerosis and perhaps to
identify asymptomatic individuals as appropriate candidates for aggressive
primary prevention.76, 77 Several acute phase reactants have been studied as
potential markers of low grade inflammation including erythrocyte sedimentation
rate (ESR), white blood cell count (WBC), fibrinogen, and CRP.78
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Traditionally, ESR has been the standard used to monitor the
inflammatory response. Erythrocyte sedimentation rate is a measure of the rate
at which red blood cells (RBC) settle to the bottom of a test tube containing
normal saline, leaving the blood serum visible above. The sedimentation rate is a
measure of how far the top of the RBC layer has fallen in one hour.79 The
sedimentation rate is larger with increasing levels of inflammation. Normal
sedimentation rate, using the Westergren method, is 0 - 15 millimeters per hour
for males and 0 - 20 millimeters per hour for females.79
There are limitations to the use of ESR in measuring inflammation. It is
non-specific, is altered by normal physiological occurrences, has low sensitivity
and changes in ESR are slow and occur for variable amounts of time.80, 81
Sedimentation rate is also affected by ambient temperature and is influenced by
RBC disorders, pregnancy and smoking.81 For these reasons, ESR is not
considered for use in predicting cardiovascular disease.
Two other commonly used tests for inflammation are fibrinogen levels and
WBC. Fibrinogen is a protein synthesized by the liver which is necessary for
normal blood clotting. It has been established as an independent risk factor for
cardiovascular disease.82 Normal fibrinogen levels range from 150-400 mg/dl.79
The use of fibrinogen has not gained widespread acceptance and it only
enhances the prediction of future events by established risk factors by 8%.83
A WBC count can be an indicator of an infection, inflammation, or allergy.
It is a very non-specific marker of inflammation. Normal clinical values for WBC in
adults range from 4.5 x 106 to 11 x 106 cells/L.79 Elevations in WBC count have
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been found to be useful in predicting coronary heart disease (CHD) mortality
independent of other CVD risk factors.84 However WBC levels have mainly been
studied in those with diagnosed CVD. Few studies have assessed the
association of WBC with CVD events in apparently healthy individuals and these
results have been mixed.84
C – Reactive Protein
Recently, a protein known as CRP has been investigated as a monitor of
the acute phase inflammatory response. C-reactive protein is a protein secreted
by the liver during a systemic acute phase response of the immune system. The
liver produces CRP in response to secretion of tumor necrosis factor (TNF-α),
interleukin-1 (IL-1), and interleukin-6 (IL-6) by the adipose, muscle and other
tissue when damage is occurring.85, 86 Interleukin-6 is a major hepatic stimulant
and levels are directly correlated with CRP levels.87 C - reactive protein is a part
of the body’s inflammatory cascade activating neutrophils, inhibiting platelet
aggregation and facilitating cytotoxic reactions.88 Its role is to bind with
Immunoglobulin G (IgG) to assist in signaling further release of IL-1, neutrophils
and macrophages and to bind with neutrophils to prevent their adhesion to
endothelial cells.88 Through this process, CRP increases the scavenging and
clearing of damaged cell particles. The end result is an increase in phagocytosis
of foreign bodies.
It has been determined that in apparently healthy individuals, CRP levels
can predict the risk of coronary events89, 90 and risk of plaque rupture in the
cardiovascular system.80 In several studies, CRP was a better predictor of
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cardiovascular (CV) events than low-density lipoprotein cholesterol (LDL),
fibrinogen or WBC count.76, 77 Plasma levels of CRP may have a higher
prognostic value than the severity of coronary stenosis91 or LDL cholesterol
level.92 In apparently healthy men and women, elevated levels of CRP are a
strong predictor of cardiac events. In a study by Ridker, CRP was the single
strongest predictor of risk and only CRP and the ratio of total cholesterol to HDL
cholesterol were independently predictive.80
Acute coronary syndromes may be indicated by elevated levels of CRP.
Elevated baseline levels of CRP have been associated with sudden cardiac
death.89 Prediction of new coronary events is consistent with assays of hs-CRP
in patients with unstable angina93 and acute myocardial infarction.77 C-reactive
protein is an independent risk factor of acute coronary syndromes even after
controlling for other Framingham risk scores.73 Atherosclerotic progression is
positively related to CRP levels. Cosin-Sales et al.94 found assays of hs-CRP
correlate with symptoms and electrocardiogram (ECG) markers of myocardial
ischemia. A correlation was also found between CRP and biochemical markers
of endothelial dysfunction95 and growth of new atherosclerotic plaque.96 Elevated
levels of CRP in patients with coronary artery disease (CAD) were associated
with impairment of the systemic endothelial vascular activity and when CRP
levels normalized, there was a corresponding enhancement in endothelial
vascular activity as detected by improvements in blood flow.97
Characteristics of C-Reactive Protein: C-reactive protein is detectable in
the plasma and has a half life of four to seven hours. During an acute phase
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inflammatory response, elevations of CRP begin within four to six hours, doubling
every eight hours, with peak levels reached within 24 to 48 hours. The levels of
CRP remain elevated while the inflammatory response persists, but decline
rapidly once the acute response is terminated. Normal levels are restored within
two to seven days.80, 81 These characteristics make CRP a sensitive indicator of
inflammatory conditions.
This was not always the case. Less than ten years ago, the standard
assays of CRP were sensitive only in the 3 - 8 mg/L range.98 Normal
concentration levels in the plasma are less than 0.5 mg/L with variations from 0.1
to 10 mg/L of blood plasma considered normal.79 The previous measurement
method was not sensitive enough to detect small fluctuations in baseline values.
The development of a high sensitivity assay of CRP (hs-CRP) has prompted a
reexamination of the use of this protein in determining the presence of an
inflammatory response.
C-reactive protein levels increase slightly with age and are easily
measured from the blood with high sensitivity assay. High sensitivity CRP testing
allows detection down to 0.1 mg/dl or even less.80 Levels of CRP are unaffected
by external conditions and are much less affected by other diagnoses than are
ESR and WBC count. The exceptions include local infection and autoimmune
diseases. In fact, in diseases such as lupus erythematosus and rheumatoid
arthritis, CRP is used to monitor acute exacerbations.79
High individual variations were found in CRP levels.99 This variation can
be around 60% and can be caused by minor trauma.100 Levels of CRP vary and
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can increase to 17mg/L or higher with infection, muscle damage or any stimulus
that causes inflammation. Mattusch et al. noted in a study of runners, that CRP
levels were elevated in subjects with a knee injury and a systemic infection.48
Within subject variation of CRP is 4 to 6 x greater than that of cholesterol.100
Because of the fluctuation and high variability of CRP, Kushner, et al. suggest
obtaining two separate tests to avoid false positives when infection is possible.100
Despite the tremendous acute variations in CRP levels, long term
circulating concentrations show consistency and these levels have been related
to risk of cardiovascular events.12, 101 Recommendations are to use levels below
5mg/L when using CRP as an indicator of cardiac risk.12 Levels above 5mg/L
should be investigated for an infection or other pathology.76 Ridker et al stratified
cardiovascular risk levels into low, moderate, and high corresponding to CRP
levels of < 1, 1 to 3, and > 3 mg/L.102
Exercise and CRP: The evidence supporting the benefits of physical
activity in the prevention of cardiovascular disease is overwhelming.58 Physical
activity is inversely linked to blood pressure, body mass index, and glucose
intolerance, all risk factors for cardiovascular disease. In previous
epidemiological studies, CRP levels follow the same pattern of inverse relation to
CVD.
The association between physical activity and reduced coronary heart
disease risk may be mediated by the anti-inflammatory effects of regular physical
activity.13 Investigators in several studies have shown inverse relationships
between routine physical activity level and concentration of acute phase
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inflammatory reactants such as fibrinogen and CRP.47-49, 103 An increase in
leisure time physical activity has been positively correlated to lower levels of CRP
and fibrinogen.58 Abrahamson and Vaccarino found that regular physical activity
is independently associated with lower levels of elevated inflammation markers,
particularly CRP.13 Geffken et al found lower levels of CRP, white blood cells and
fibrinogen with higher levels of total physical activity.47 Rohde et al observed that
men who exercised more than one time per week had lower levels of CRP than
those who did not exercise.104
Danesh et al, in 1998, reviewed previous studies of physical activity and
CRP finding the relative risk of CVD to be 1.7 in the highest versus the lowest
tertiles of CRP concentration (relative risk = 1.0).78 In 2000, Danesh et al
performed a meta-analysis of CRP studies and the relative risk for CVD and this
relative risk was 1.9 for the highest versus the lowest tertiles of CRP level
(relative risk = 1.0).101 The strongest associations of CRP and CVD were found
with both smoking and BMI with an odds ratio for CHD of 2.13 after adjustments
versus the relative risk of 1.0 in the lowest CRP category.101
C-reactive protein may be a valid way of monitoring tissue inflammation
and damage at the systemic level.105 It appears that sporadic exercise
temporarily increases the inflammatory response while regular exercise lowers
it.106 Acute elevation of inflammatory markers has been observed and
associated with vigorous activity, most likely caused by muscle and joint
inflammation.48, 107-109 High intensity, short duration exercise may cause more
inflammation than lower intensity, longer duration exercise.110 Meyer et al
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reported that repeated short bouts of cycle ergometry caused a greater acute
phase response than a single longer bout of cycling exercise.111
When tissue damage or acute inflammation occurs, regardless of the
cause, changes in CRP levels are not immediate. C-reactive protein levels begin
rising between 4 and 8 hours after activity initiation and remain above baseline at
24 hours.112 Bench stepping for 40 minutes revealed CRP unchanged
immediately post exercise. However, at one-day post exercise, CRP levels were
at their highest at 3.9 mg/L returning to basal levels 2-3 days post exercise.113
The effect of exercise on CRP seems to mimic that of an inflammatory response
to an infection or injury.
CRP response to exercise may be attenuated with daily high intensity
exercise. Trained athletes may have a diminished acute phase reaction and a
suppressed inflammatory response due to adaptation to a regular exercise
routine.48, 106 Regular exercise may also decrease baseline levels of CRP.108
Adaptation of the inflammatory response may occur in trained athletes105 if the
athletes train regularly and avoid over-training. High sensitivity assay of CRP
under resting conditions taken before and after 9 months of training fell from 1.19
mg/L to 0.82 mg/L as the mean distance run per week increased from 31 + 9 km
to 53 +15 km.48 Regular training lowered CRP in both wrestlers and rowers.99
Increases in endurance exercise reduced baseline levels of CRP after 12 weeks
in patients enrolled in cardiac rehabilitation.114, 115 No acute phase responses
were observed after training in elite female netball and soccer teams.109
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Intensity, duration and type of exercise affect the degree of the
inflammatory response. In contrast to the above investigations, researchers
found significant elevations of plasma CRP levels during and after competitive
exercise in studies involving marathoners, ultra-triathlon and triathletes. During
an ultra-triathlon of 48 hours, CRP levels continually increased throughout the
race116 and were elevated after a 56 km footrace.117 Male marathoners had
increases in plasma levels of CRP at 16 hours after racing. Levels of IL-6, the
stimulator of CRP, were increased immediately post exercise and at 1-hour post
exercise.112 In a canoe, cycle and running triathlon, CRP levels increased 300%
within 24 hours of the race.118 Return to baseline levels may occur within 2 to 7
days depending on intensity of exercise, health and fitness level.80, 81 The
differences in acute phase responses may be due to the excess stress and
damage caused by the vastly different levels of intensity and distance between
training for races and the actual competition.
Eccentric exercise is known to cause more tissue damage than
concentric and may therefore cause a greater inflammatory response.108, 119
Among athletes, female and male swimmers and male rowers had lower CRP
baselines than control subjects, cyclists, runners and soccer players.108
Swimmers and rowers training at least four days per week had significantly lower
baseline CRP values than untrained controls. Both swimming and rowing involve
minimal eccentric exercise. Values for the control group were 0.5 mg/ml,
compared to the lower values of swimmers at 0.10 mg/ml (p< 0.001) and of
rowers at 0.26 mg/ml (p < 0.01).49 In the same study, athletes in sports involving
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eccentric activities (runners, cyclists and soccer players) had baseline CRP
values that did not differ from that of control subjects.
When looking at the NHANES study that surveyed activity level of 17 to 65
year olds, regular jogging and aerobic dancing but not cycling, swimming or
weight lifting were associated with statistically significantly lower levels of
CRP.108 This is similar to the findings of Tanasescu et al. that walking, running
and weight training lowered the risk of CV mortality but cycling and swimming did
not.120 These results contrast those of King et al.108 It is unclear what intensity
levels were performed in the latter 2 studies using physical activity
questionnaires.
Higher levels of activity and fitness seem to correspond to lower baseline
levels of CRP. In general, CRP levels are inversely related to average daily
physical activity. Elevated CRP levels were found in 21 sedentary, 17 lightly, 13
moderately and 8 vigorously physically-active study participants.58 Across fitness
levels there is an inverse relationship with CRP.121, 122 However, the acute effect
of exercise on CRP levels appears to vary with the type of activity, intensity level,
individual fitness level and duration of activity bout.76
Summary of CRP: The inflammatory marker known as CRP may be useful
in conjunction with other tests such as LDL cholesterol level in detecting risk for
cardiovascular disease in at risk patients. Ridker et al recommend the use of
CRP in conjunction with LDL cholesterol levels to assist in improving prediction of
CVD events such as myocardial infarction and stroke.73 In athletes, the levels of
CRP tend to vary with level of tissue damage during exercise but levels attenuate
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as the body adapts to a training program. Overall, baseline levels of CRP
decrease with increasing levels of physical activity indicating a lower risk for
CVD.
Physical Activity
The terms physical activity and physical fitness are often used
interchangeably in conversational language. Researchers recognize the two
terms separately. Physical activity is defined as “any bodily movement, planned
or unplanned, produced by skeletal muscles that results in energy expenditure.”2
Exercise is a subset of physical activity and refers to “planned, structured and
repetitive bodily movement done to improve or maintain one or more of the
components of physical fitness.”2
Physical fitness is “a set of attributes that a person has that relate to the
ability to perform physical activity.”2 It is the ability to perform daily tasks with
vigor and alertness, without undue fatigue and with ample energy to enjoy leisure
time pursuits. The definition of physical fitness can differ between athletic
performance and health fitness. Components of health fitness include
cardiorespiratory endurance, muscular strength and endurance, flexibility and
body composition.33 The American College of Sports Medicine (ACSM) reports
that “cardiorespiratory physical fitness is strongly associated with health benefits
in the general population”56 and is directly related to habitual physical activity.2,
122

Findings relating cardiovascular disease and health benefits of activity are

more consistent for studies using cardiorespiratory fitness than using reported
physical activity.2 Cardiorespiratory or aerobic fitness will henceforth be referred
24

to in this paper as physical fitness. Both physical activity or the accumulation of
movement over a specific time period, and physical fitness or the average of the
daily activity intensity accumulated, have been used to quantify amount and
intensity of habitual physical activity or energy expenditure.
Quantification Issues
Understanding the basic characteristics of habitual activity is important to
understanding the relationship of physical activity (PA) to chronic diseases such
as cardiovascular disease.123 Yet there is no standardization of measurement
methods of physical activity in the literature.124 This is because the quantification
of energy expenditure and habitual physical activity is complex. It is difficult to
accurately and objectively measure the total amount of physical activity over the
course of the day without disrupting the normal course of activities known as
“free living.”2 Direct measurement of physical activity is possible using
techniques such as direct calorimetry, expired gas analysis or doubly labeled
water but these techniques are difficult and often expensive.125 Therefore, direct
measurement of physical activity is primarily used in smaller scale studies.
Indirect measures are more practical in larger studies and many indirect
measurement techniques have been correlated to daily physical activity.
There are two predominantly used methods to quantify amount of regular
activity when studying all-cause mortality and cardiovascular disease mortality.
They are cardiovascular physical fitness (fitness level) and self-reported physical
activity. Self-reported physical activity is measured using a leisure time physical
activity (LTPA) questionnaire.124 The main differences are that physical fitness is
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an objective measure of habitual physical activity and the LTPA questionnaire is
a subjective estimation of physical activity over time.
Physical Activity Recommendations
In 1996, the Centers for Disease Control published the Surgeon General’s
report2 on the importance of physical activity for health and for the prevention of
disease. This report identified risk factors for cardiovascular disease. They
include age greater than 45 for males and greater than 55 for females, family
history of CVD, high blood pressure (hypertension), diabetes mellitus or insulin
resistance, smoking, high cholesterol (dyslipidemia), obesity and lack of physical
activity.
Prior to 1996, recommendations of the American College of Sports
Medicine (ASCM)33, 56 and Centers for Disease Control (CDC)2, 56 suggested that
vigorous activity levels of 15 to 60 minutes duration, 3 to 5 days per week were
necessary for health benefits.2, 56 These recommendations were based on
analysis of the lifestyles of young, healthy individuals. In the early 1990’s, the
Centers for Disease Control examined the evidence collected on physical activity
in middle aged and older adults and the results were incorporated into the 1996
report, “Physical Activity and Health; A Report of the Surgeon General.”2
The 1996 Surgeon General’s report established new guidelines for
physical activity. To decrease risk of both CVD and all-cause mortality, “at least
thirty minutes of moderate level physical activity on most, preferably all, days of
the week” is recommended. Moderate activity is defined as 3 to 6 metabolic
equivalents (METs), with 3 METs being similar to the level of a brisk walk.2 The
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1996 Surgeon General’s report was based on the results of several large cohort
studies including the Framingham Heart,126 the Harvard Health127 and the
Aerobic Center studies.124, 128-130 These studies either used self-reported physical
activity or physical fitness levels as measures of physical activity.
Self-reported Physical Activity: There were seven major studies that
examined the relationship of self-reported physical activity and CVD mortality.2
The Framingham study related self-reported activity levels to cardiovascular
disease mortality in 4000 men and women.126 This study identified and
established many of the current risk factors for heart disease including physical
inactivity, smoking, hypertension, hyperlipidemia, insulin resistance and age. In
the Harvard health study, Paffenbarger et al. observed self-reported activity of
Harvard alumni and found that smoking, and physical inactivity were related to
higher mortality rates from CVD.127 A trend of decreased death with increased
self-reported activity level was also observed for both cardiovascular and allcause mortality.
Cardiorespiratory Physical Fitness: Findings relating physical activity to
CVD are even more consistent for studies using physical fitness than using selfreported physical activity.2 Five cohort studies related physical fitness to CVD
mortality.2 Blair et al confirmed that there is an inverse relationship between
cardiorespiratory fitness level and both CVD and all-cause mortality.124, 128-130
From the collected evidence, a dose-response relationship is suggested between
physical activity and risk of both CVD and all-cause mortality.124 There were
greater benefits for those that were the most active however, it was concluded
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that even moderate intensity physical activity can significantly effect
cardiorespiratory performance and provide health-related benefits.2
Despite these landmark studies, there are many questions that remain
unanswered. Exercising at or above the Surgeon General’s recommendation is
likely to decrease all cause mortality but the best method of acquiring this activity
is not yet clear.124, 131 The optimal type, intensity, frequency, duration or bouts by
which this activity should be accumulated has not yet been established.124 One of
the difficulties encountered in establishing optimal activity for prevention of
cardiovascular disease is in the measurement of physical activity during free
living or unrestricted movement during daily life.
Measurement of Physical Activity
Self-Report: Physical activity is the total amount of movement performed
by an individual above the basal metabolic rate (BMR) which is the minimal
energy expenditure necessary to survive. Physical activity is most often
assessed in epidemiological studies through self-report activity surveys. These
are questionnaires that rely on recall of LTPA for various time periods ranging
from one day to six months. These assessments are easily administered and
user-friendly however questionnaires are subjective and depend on an
individual’s recall and perception of activities.124 Analyses of self-reported activity
reveal considerable variability and only moderate external validity.2 Estimated
error associated with LTPA questionnaires ranges from 35 to 50 percent
depending on the populations studied.10, 11
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Other indirect and objective methods of measuring physical activity use
heart rate monitors or motion detectors such as pedometers and accelerometers.
These devices allow estimation of physical activity levels that are less accurate
than direct methods while still providing an objective measurement of physical
activity for longer periods at reasonable cost.
Pedometer Studies: Pedometers are devices that measure vertical
excursion at the hip during walking giving raw data in total number of steps.
Because many daily activities incorporate walking, this information can also be
used to monitor free living. Data provided by the pedometer not only consists of
total steps, but calculations of distance traveled and estimates of energy
expenditure can also be obtained.132 During controlled walking and running,
correlations of r = 0.84 to r = 0.93 of pedometers with accelerometers have been
observed.133 Some health promotion programs, such as 10,000 steps and Active
Living, Everyday®, promote the use of pedometers to monitor daily activity levels
and to provide both feedback and goal-oriented motivation to increase physical
activity levels. Benefits of using these devices include their low cost,
unobtrusiveness and ease of both use and output interpretation.132, 134
Pedometers range in cost from 10 to 50 US dollars.135
Sensitivity of pedometers can differ by brand so some care must be taken
if using for research purposes.136 Particularly at slow walking speeds (less than
2.4 miles per hour), many of the pedometers underestimated actual steps and
distance.136 In distance calculation, some of the error can be attributed to stride
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length as well as step count. Stride length tends to vary with walking speed
however only one stride length setting is permitted in the pedometer memory.
Pedometers are designed to capture ambulatory activities and because of
this, one of the major limitations of the device is the inability to capture common
physical activities such as bicycling, swimming and weight lifting.132 During uphill
and downhill walking, pedometers may not measure number of steps with
accuracy.136 Pedometers will tend to underestimate the energy cost of most
lifestyle activities including stair climbing, and those involving upper extremity
activity.136 Pedometers are best at capturing steps, less accurate in calculating
distance and least accurate at determining energy expenditure.134 Despite the
limitations mentioned, pedometers are useful in capturing ambulatory activity
throughout the day and can provide an extremely useful and objective gauge of
an individual’s overall ambulatory activity levels at low cost with little
inconvenience.136 With researchers finding recall of non-structured moderate
level activities to be less accurate than more structured or vigorous exercise,
pedometers can be beneficial to objectively measure activity whether incidental
or intentional and to provide feedback to improve motivation.134
Accelerometers: Activity monitors or accelerometers are a commonly used
method of assessing physical activity during free-living. Accelerometers are
recognized as valid tools for assessing free living and have gained acceptance
as, “Possibly the most effective method of obtaining objective information about
physical activity level.”137 These monitors allow for free-living without the
constraints induced by direct calorimetry methods. Though the monitors are less
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accurate than doubly labeled water procedures or direct calorimetry methods,
activity monitors provide a convenient, simple and efficient method of objectively
quantifying physical activity over long periods of time at much lower cost.11, 137
Accelerometers eliminate some of the inherent limitations of self-report
questionnaires including subjectivity of frequency, intensity and duration while
still allowing for estimation of total energy expenditure.138, 139 They are more
objective and precise than pedometers or LPTA questionnaires, and unlike LPTA
questionnaires are free from random or systematic error due to recall or self
report.10, 140, 141
Accelerometers measure motion in three orthogonal planes of movement
and are therefore sensitive to non-ambulatory movements.133 They provide a
standardized description of free-living physical activity in real time including
intensity, duration and frequency.138 They can record and store activity data for
extended periods and have adjustable epochs (time periods for which activity is
averaged).123, 142 A reliability study of four different accelerometers to actual
energy expenditure revealed interclass correlation coefficients ranging from 0.62
to 0.80.137 Comparisons of other studies showed prediction equations with
correlations up to 0.89 when looking at only walking and running activities138 and
up to 0.99 with level walking alone regardless of walking speed.133, 143 The device
discriminated among subjects in three categories, sedentary, moderately active
and active and between specific activities (such as walking, cycling and jogging)
and those with varying intensities light, moderate, and intense.144 The devices
tend to overestimate activity associated with excessive vibration such as riding in
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a motor vehicle or operating machinery133 and are somewhat limited in accurate
assessment of activities such as cycling and swimming due to the minimal
acceleration of the center of gravity when monitoring at the hip or low back.123, 138,
142

Accelerometers costs range from 50 up to 400 US dollars.135
Accelerometers and pedometers are objective measures of physical

activity that can assist with determining which individuals are meeting or
exceeding the recommended minimal levels of physical activity. Each device has
its limitations and advantages. The high correlations seen between the
accelerometer and pedometer by Tudor-Locke et al.145 and Schneider et al.134 (r
= 0.80 - 0.86) would allow either device to be utilized particularly if only relative
values are required for analysis.
Physical Fitness: Another method used for measuring physical activity is
fitness level. Cardiorespiratory physical fitness is directly related to habitual
physical activity 2, 122 and is the type of fitness most strongly associated with
health benefits in the general population.56 The benefit of using fitness as a
measure of physical activity is that through objective measurement, there is a
reduction of the bias that results from self-reported activity levels such as LTPA
questionnaires.122 In fact, findings are more consistent for studies using fitness
than using physical activity.2
The standard for fitness measurement has traditionally been VO2max.
This is defined as, “The maximal capacity of the cardiovascular system to provide
oxygen to muscle cells during sustained exercise.”146 It is usually determined
using an incremental exercise protocol on a motorized treadmill or bicycle
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ergometer.147 Large cohort studies have examined VO2max, relating it inversely
with all-cause and CVD mortality.128, 130 The assessment of VO2max requires
exercise to a maximal volitional exertion level and a high level of motivation by
the subject.148 This intensity of exercise can be sustained for less than one
minute.147 Specialized equipment is necessary to measure expiratory gases and
it is difficult even for the best athletes to perform well because it requires
exercising to exhaustion.147 Athletes and trained subjects may be able to tolerate
this maximum intensity effort however for sedentary individuals, those with health
problems and those at risk for cardiovascular disease, this measure is potentially
dangerous and generally not well tolerated.148 Because people spend the
majority of their time in submaximal levels of activity, a method that quantifies the
capacity of an individual to exercise for longer periods of time is more appropriate
for the general population.147 There are two such measurements that exist,
lactate threshold (LT) and ventilatory threshold (VT).
Chemistry of exercise: During exercise, lactate (La-) and hydrogen ions
(H+) are produced by the muscle. These products are often utilized within the
muscle as energy sources for the Krebs cycle and glycolysis. Excess La- and H+
ions are released from the muscle into the bloodstream.
Sodium bicarbonate (Na HCO3) is present in the bloodstream. Sodium
bicarbonate dissociates into Na++ HCO3-. The Na+ ions buffer La- and the HCO3buffers the H+. In this form, both the H+ and the La- can be transported through
the bloodstream. The excess La- is used by the heart, the brain, and muscles in
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other parts of the body as an energy source. The liver also takes up La- using it
to produce glucose through the process of gluconeogenesis.149
The H+ ions are buffered by the bicarbonate HCO3- demonstrated by the
equation: H2O +CO2 = H2CO3 = H+ + HCO3-. The direction of this equation is
driven by the acidity or the amount of H+ ions present. If there are more H+ ions
being produced, the equation is driven to the left, with more H2O +CO2 the result.
The extra CO2 causes an increase in the partial pressure of CO2 in the blood.
This excess is eliminated through formation of additional HCO3- and through gas
exchange in the lungs via lung ventilation. The respiratory exchange ratio (RER)
is the ratio of the volume of carbon dioxide (VCO2) expired to the volume of
oxygen (VO2) consumed. Normal values during steady state exercise vary
between 0.7 and 1.0.147, 150 While in steady state exercise, the production rates of
La-, H+ and CO2 are equal to their elimination rates. Throughout steady state
exercise, ventilation increases linearly with both oxygen consumption and carbon
dioxide production. The term ventilatory equivalent (Ve) is used to describe
minute ventilation and is generally used in a ratio of Ve to oxygen consumption
(Ve/VO2) or to carbon dioxide expiration (Ve/VCO2).150 During steady state,
Ve/VO2 averages between 20 and 25 liters of air per liter of O2 consumed.147, 150
When the body exceeds its aerobic capacity, both La- and H+ accumulate
in the bloodstream and surpass the system’s utilization of La- and buffering
capacity of H+ ions. The buffered H+ is combined with bicarbonate and expired
into the air as excess CO2. When the production of La- exceeds the buffering
capability and uptake/utilization, the LT is reached.151 The LT can also be defined
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as the maximum intensity at which a steady state of exercise can be
maintained.33, 147
Above LT, acidosis develops accompanied by increases in the partial
pressure of CO2. The increase in acidosis causes ventilation to increase to
facilitate O2 and CO2 exchange helping rid the body of the excess CO2. As the
intensity of exercise continues to increase, the production of H+ ions exceeds the
body’s ability to buffer the ions and ventilation starts to increase in a non-linear
fashion. This point where ventilation deviates from the progressive linear
increase of steady state is called the ventilatory threshold (VT).152
When below VT, an individual can achieve a steady state of activity where
not only heart rate but VO2 and VCO2 expiratory gases remain constant. When
above VT, the kinetics of CO2 change because CO2 is not being produced solely
as a consequence of aerobic metabolism. Additional carbon dioxide is produced
and expired when the acid buffered by the bicarbonate system exceeds the
capacity of the system.153 The excess CO2 causes the respiratory exchange ratio
(RER) to increase above 1.0.147, 150 As a result, there is an increase in CO2
without an increase in O2 at VT. The accumulation of H+ ions lowers the blood pH
altering energy production and muscle contraction.151
The accurate measurement of LT requires an invasive procedure to obtain
samples of blood to measure levels of lactate. These measures must be
repeated at least once every minute. Because of frequent sampling and the
variation of blood lactate concentrations depending on sample site, the standard
procedure is to use either central venous or arterial samples through the use of a
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catheter line. Medical supervision is necessary and there is a potential risk for
complications particularly with sampling centrally.147
Ventilatory threshold is considered an indirect measure of LT.154, 155 It is a
noninvasive method of determining the LT by plotting ventilation and respiratory
data. The LT and the ventilatory threshold are known to occur at similar time
periods however they are not directly linked.151 When the metabolic needs for
oxygen in the muscle exceed the capacity of the cardiopulmonary system to
supply them, there is a sudden increase in anaerobic metabolism and lactate is
formed.151 The level of activity at VT corresponds with intensity that causes the
first rise in blood lactate levels.152 Strong relationships have been established
between VT and LT with high correlations between LT and VT found in studies
by Davis in 1976 and Caiozzo in 1982 (r = 0.88 to 0.95).154, 155 High correlations
with LT have been found for V-slope, Excess CO2 (Ex CO2) and ventilatory
equivalent, (all measures of ventilatory threshold) with correlation coefficients at
0.81, 0.94 and 0.87 respectively.156 Using a combination of the above methods to
determine VT, Gaskill et al. (2001) found high correlations with LT (r2 =
0.9850).156
It has become more common to use VT as a basis for determining fitness
level and exercise intensity.156 Researchers have demonstrated that VT is an
accurate method of determining fitness level and have shown a positive
correlation between daily physical activity intensity and VT.156 Scientists from the
HERITAGE Family study suggest, “VT is more related to self-reported activity
levels, activity level during activities of daily living, intensity of prescribed physical
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work and maximal sustainable work than is VO2max.”156 There are several
different methods of determining VT including ventilatory equivalents (VE),
excess CO2 (Ex CO2), and modified V-slope (V-slope). All three methods use
graphing techniques and require determination of the first non-linear change or
breakpoint in the slope. These methods are described below.
The ventilatory equivalent method plots Ve/VCO2 and Ve/VO2 previously
defined as the volume of air ventilated divided by the volume of CO2 expired
(Ve/VCO2) and O2 consumed (Ve/VO2) (see figure 1). This method requires
locating the intensity of activity that causes the first rise in the ventilatory
equivalent of oxygen (Ve/VO2) without a concurrent rise in the ventilatory
equivalent of carbon dioxide (Ve/VCO2). This method is dependent on the
ventilatory response to exercise.157 Caiozzo et al. recommended VE/ VO2 as the
method of determining VT that was best correlated with La- (r = 0.93, r2 = 0.77 to
0.92).155, 156
The excess carbon dioxide method determines the intensity of activity that
causes an increase from steady state production of CO2 to an excess of CO2
(see figure 1). Excess CO2 is calculated as ((VCO2/VO2 ) - VCO2).158 This method
relies on the detection of excess CO2 expired when threshold is reached and has
correlational values that explain 82 to 94 percent of the variance (r2 = 0.82 to
0.94).156
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Figure 1

Visual Determination of Ventilatory Threshold
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Figure 1: Visual determination of ventilatory threshold (VT) using three methods.
The arrows designate the choice of VT in these sample graphs from one subject.
A. Ventilatory equivalence method: VT is chosen at the time corresponding to the
first sustained rise in the ventilatory equivalent of O2 (VE/VO2) without a
concurrent rise in the ventilatory equivalent of CO2 (VE/VC O2). B. Excess CO2
method: VT is chosen at the time corresponding to the first sustained rise in
excess CO2. C. Modified V-slope method: VT is chosen at the VO2 value
corresponding with the increase in slope of VO2 -VCO2 plot. From: Gaskill SE,
Ruby BC, Walker A, Sanchez O, Serfass R, Leon A. Medicine and Science in
Sports and Exercise, 2001;33(11):1841-1848.
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The V-slope method plots the minute production of carbon dioxide (VCO2)
versus the minute utilization of oxygen (VO2). The V-slope method is dependent
on proton buffering capability of the bicarbonate system. There is a breakpoint or
change in slope that occurs on the graph of VCO2 versus the VO2 that
corresponds with the time at which VCO2 rate surpasses VO2 rate157 or when the
slope increases from less than one to greater than one (see figure 1).159 Again, a
change in CO2 expiration is being detected. This method was determined to be a
sensitive index and was the most reliable detector of LT with r2 values ranging
from 0.81 to 0.95.156, 160, 161
Though the separate analysis of each method reports good correlations
with LT, the combination of the three methods appears to have even greater
accuracy. The combining of the three methods (V-slope, Ex CO2 and Ve/VCO2)
to determine VT was examined by Gaskill et al. The combination of the three
methods was shown to have high correlation with LT across fitness levels in
adults (r = 0.95 to 0.98).156 Correlations of RER to VT have been moderate (r =
0.73 to 0.86) however monitoring changes in RER in real time can assist with
approximating VT during exercise testing and can be used as a confirmation of
VT attainment.157
Fitness Level and Cardiovascular Disease
Fitness levels have been shown to be a strong predictor of CVD
mortality.129, 162 When fitness levels were divided into quintiles, being in the
lowest fifth of fitness was an important precursor of CVD mortality.52 Being the
least fit is one of the stronger predictors of all cause mortality in both men and
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women comparable to smoking, and stronger than blood pressure or
cholesterol.129 Even in those who have other risk factors for cardiovascular
disease, higher levels of fitness provide protection from CVD mortality.52, 163
There is evidence that the relationship between fitness and both all-cause
and CVD mortality is one of dose-response.124 There is a strong inverse
relationship present for both men and women between fitness level and CVD
mortality.129, 164 Inverse dose-response relationships are strongest for all-cause
and cardiovascular mortality; however, lower incidence rates for hypertension
(high blood pressure), obesity, and type 2 diabetes mellitus have also been
consistently reported in the literature.56 In general there is a stratification of
mortality from unfit to fit.165, 166
Those who were sedentary and became fit improved their cardiac risk
profile, and had decreased mortality rates. Their risk was significantly reduced
approaching that of a moderately fit individual.165, 167 Beginning and maintaining
an exercise program later in life was more beneficial than starting as an athlete
and becoming sedentary.167 This held true in the Nurses Health study34 and in
the Aerobics Center Longitudinal study.168 Unfit men who became fit had an
estimated relative risk (rr) for CVD mortality of 0.52 compared with those who
remained unfit (rr = 1.0).168
There is an association between usual habitual physical activity and
aerobic fitness and risk for chronic disease.45 It would be useful to have a method
of measuring an individual’s activity level without disrupting free living. Ventilatory
threshold is a better marker of habitual physical activity than VO2max.152
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Ventilatory threshold has been shown to be related to daily activity levels and an
accurate measure of chronic activity levels by both Tamai169 and the HERITAGE
Family study.156 Tamai et al reported that VT was correlated with discretionary
physical activity (r = 0.80), work hours per month (r = 0.71) and exercise hours
per month (r = 0.67).169 Participants in the HERITAGE family study who were
sedentary had a mean baseline oxygen consumption at VT (VO2vt) of 17.7 + 4.1
ml/kg/min.152 These outcomes are consistent with previous researcher’s results
that activities of daily living require a VO2 of 14 to 21 ml/kg/min (4 and 6
METS).169 Values for VT in athletes were maintained between 42 and 47
ml/kg/min over 15 years of training.169
The relationship between habitual physical activity and fitness is further
substantiated when looking at training studies. Ventilatory threshold is a better
predictor of performance in endurance events than VO2max.170 Greater
improvements in VO2vt are seen when training levels are set relative to VT.
Participants in the HERITAGE family study who exercised at levels above VT
had greater improvements in submaximal fitness than those who exercised at
levels at or below VT.156 Training at levels just above threshold increased VO2vt
by 48 percent in study by Henritze et al.171 Elite athletes routinely use VO2 as an
assessment of training intensity and effectiveness152 but may be better served
using VT as an indicator particularly for endurance activities.
Subjective Measurement of Ventilatory Threshold: The Borg scale rating
of perceived exertion (RPE) was developed to subjectively assess intensity of
exercise or physical activity.172 This method can also be used to determine
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ventilatory threshold (VT) and the rate of lactate accumulation.56 The RPE scale
can be useful in rapidly determining VT without expensive equipment such as a
metabolic cart. Researchers have established that RPE is of practical value to
prescribe exercise training intensities in sedentary adults, recreational athletes
and elite athletes.
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Swaine et al observed that regardless of habitual exercise

level and training mode, subjects selected a common intensity of effort that was
compatible with the described RPE.
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Feriche et al found no significant

differences between mean values of VT and RPE at threshold and recommend a
fixed value (12 - 13) of the RPE scale to detect the exercise intensity
corresponding to VT.175
Physical Activity and Cardiovascular Risk
Analysis of the risk of cardiovascular disease suggests that physical
activity, most commonly assessed using a LTPA questionnaire, is inversely
related to mortality and morbidity in both men and women.176 Based on leisure
time physical activity, median relative risk for mortality was 0.66 (95% CI) for the
most active, fit women versus their sedentary counterparts who had a relative
risk of 1.0. This is similar to the 0.70 (95% CI) median relative risk found for men
in the same fitness levels.177 Researchers found that women also had
stratification of mortality risk, from lowest to highest: active, inactive to active,
sedentary.165 Haapanen et al observed that total amount of activity was related to
lower CVD risk in men, but not in women.46 An inverse linear relationship was
found between running amount and CVD risk. 178
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In a meta-analysis of physical activity and CVD disease, Lee noted that 33
out of 44 studies showed an inverse relationship between amount of physical
activity and all cause mortality.179 Five out of ten studies had a minimal threshold
of physical activity that decreased mortality.179 These numbers are explained in
the following section.
It is important to note that physical activity must be current and persistent
to produce the desired health benefits including cardiovascular protection.5, 14
Only ongoing or current exercise, protected against CVD.167 Increasing activity
from sedentary to high levels in mid to advanced age was better than being an
athlete and becoming sedentary with no vigorous activity later in life. These
physically active people had a 62% lower risk than those who became
sedentary.167
Physical Activity Parameters
The Surgeon General’s report recommends at least 30 minutes of
moderate level physical activity, most if not all days per week. This is the
equivalent of 2 to 2.5 hours per week, or if walking, approximately 9 miles per
week when exercise is accumulated. Does activity have to be spread throughout
the week? “Weekend warriors” are described as those individuals who are
sedentary during the week obtaining the majority of their physical activity during a
two or three day period (Friday, Saturday, Sunday). Weekend warriors who
expended great amounts of energy in only two days had a similar reduction in
risk of CVD mortality as those who were active on a daily basis.176 However,
those weekend warriors with CVD risk factors such as high blood pressure,
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obesity or smoking needed higher overall activity levels than their healthy
counterparts to provide protection against CVD mortality.176
Researchers in several studies found that there was a threshold of
minimal fitness or physical activity necessary for protection from CVD
mortality.179 For maintenance of CVD health, expenditure of at least 1000
additional kilocalories per week is necessary and seemed to be sufficient to
avert premature mortality.176 Expending greater than 2000 additional kilocalories
per week was the most beneficial for reducing risk factors of heart disease.167, 177,
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In intervention studies, investigators have found that there was a thirty to
forty percent decrease in CVD mortality in those who began brisk walking 2.5 to
3 hours/week34, 181 or who accumulated 1.5 hours of vigorous activity per week.34
In the Honolulu heart study, those who walked 1.5 miles per day had 50% lower
risk of CVD than those who walked less than 0.25 mile/day.182 A meta-analysis of
physical activity and relative risk revealed that women who walked more than
one hour per week had a relative risk of 0.80 (95% CI = 0.74 -0.87) compared to
those who were sedentary (RR = 1.0).183 In general, those who met or exceeded
the Surgeon General’s recommendations had the greatest reduction in CVD risk
however effects were seen in those with lesser amounts of daily and
accumulated exercise.
Intensity: Based on previous research, investigators suggest that
moderate levels of physical activity are sufficient to provide protective effects
against CVD mortality with more intense levels providing greater protection.167,
45

184-186

Brisk walking and vigorous exercise had similar effects on reduction of

incidence of coronary events in women in the prospective Nurses Health Study.34
In general the inverse relationship with CVD held for all activity levels. However,
all the evidence does not agree. Recently, Yu et al recommended at least eight
minutes of daily, high intensity activity for protection from CVD mortality.
Acquiring only moderate levels of activity did not appear to provide protection.187
Determination of intensity level is generally based on an absolute scale of
metabolic equivalents. These metabolic equivalents for specific activities are
based on energy requirements for a healthy, fit individual and vary greatly in
those with lower fitness level. Lee et al examined rate of perceived exertion as a
measure of relative intensity and found an inverse association of relative intensity
of physical activity to risk of CHD.188 The highest intensity category had a 0.72
relative risk (CI = 0.52 to 1.0) while the moderate category was 0.69 (CI = 0.51 to
0.94). Assessing relative intensity using RPE allows scientists to generalize
intensity from the most fit to those with physical impairments that may
necessitate much higher energy expenditure for the same activity.183
C-Reactive Protein and Cardiovascular Risk Factors
There is limited contemporary information on the distribution of CRP and
the factors associated with levels of CRP in men and women. Limited data is
available on the characteristics of those individuals with elevated CRP. Further
studies are necessary to identify the predictors of elevated levels of CRP.189 It is
imperative to further understand the interrelationship between CVD risk factors
and how to reduce the risk of CV events.
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There are six modifiable risk factors of CVD. Inflammation has been linked
to all of them. The best prediction of CVD comes from LDL cholesterol levels
however 50 to 73 percent of CV events occur in the presence of normal LDL
cholesterol levels.73 Can CRP levels be measured and used in combination with
other cardiovascular risk factors to better determine risk of heart disease in a
healthy population? There is still no good marker that exists to independently
predict the risk of CV events but CRP has been suggested to be used in
combination with LDL cholesterol levels.
Researchers in several large scale epidemiological studies have shown
that CRP is an independent predictor of cardiovascular events however
relationships between CRP and CVD risk factors have not been fully
elucidated.190 If CRP is a marker of CVD risk, how does it relate to CVD risk
factors? In a study by Godefroi et al., CRP was divided into tertiles (less than 1
mg, 1 - 2.9 mg, and 3 mg or greater). It was observed those with elevated CRP
were slightly older, more likely female, tending to be obese, less active and have
been previously diagnosed with either high cholesterol or hypertension.189
In studies in which regression analyses were used, investigators found
that measures of obesity were most often related to CRP levels. Ryu et al.191
related CRP to risk factors of heart disease in subjects greater than 50 years old
and Raitakari et al. observed that waist circumference, smoking and HDL
cholesterol accounted for 21.9% of the variance in CRP levels in participants
aged 21 to 39 years old.192 Kondo et al. examined CRP in middle aged healthy
Japanese workers and found body fat, BMI and HDL cholesterol to be correlated
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with CRP (r = 0.6, r = 0.43, and r = -0.63 respectively).193 Saito et al. evaluated
the relationships between CRP and CVD risk factors in 566 Japanese men and
women enrolled in a health check program. Univariate regression analysis
revealed a statistically significant relationship between CRP and BMI (r = 0.28),
smoking (r = 0.23), and HDL cholesterol (r = -0.22).190
Recent intervention studies looked at the effects of weight loss or a
physical activity program on CRP levels. In general, endurance training induces
changes in CRP that seem to be related to weight loss.194 Post-menopausal
women,195 obese children, and middle aged women196 had significantly
decreased CRP levels after completing an exercise program. In a 12 week
aerobic training study of obese girls by Nassis et al., improvements in insulin
sensitivity occurred without significant changes in CRP or weight loss.197 Not all
investigators agree with these findings. Okita et al. did not observe changes in
CRP and weight, however decreases in CRP were not proportional to amount of
weight loss.196
As physical activity (measured by either PA or physical fitness) increases
the level and amount of CVD risk factors decrease. Physical activity and CRP
have been linked primarily in the athlete and in those with previous CV events.
There is limited information on the amount of PA or fitness necessary to control
levels of CRP. If physical activity does reduce the risk of CVD through
attenuation of the inflammatory response, what type of relationship exists
between amount of physical activity and CRP levels? Can CRP be used as an
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overall indicator of cardiovascular health? How does the relationship between
CRP and the CV risk factors change when activity level is changed?
Several recent studies illustrate that CRP levels correspond to levels of
fitness122, 198 and self-reported physical activity.199, 200 Borodulin examined a
cross-section of Finns between 25 and 74 years old separating males and
females into four levels of self-reported conditioning and non-conditioning
physical activity. It was determined that in women, the highest and lowest
quartiles of conditioning differed in CRP levels by 27%. Pitsavos et al. looked at
four levels of self reported activity in Greeks over 18 years old finding the two
most active groups to have CRP values significantly less than the sedentary
group.200
When looking at specific at risk CVD populations, exercise training
reduced CRP levels significantly more than in the control populations.195, 201
Goldhammer observed 28 patients with CHD who participated in a 12 week
aerobic exercise program and found that those with diabetes mellitus, decreased
CRP levels by 47% and those without DM lowered CRP by 19%.201 Those with
CHD or high risk of CHD and children who are obese, had greater reductions of
CRP levels than controls.194, 195, 201
Summary
It is still unclear how much physical activity is necessary to avoid the risk
factors of CVD. Is there a minimal threshold of accumulated activity at which risk
factors significantly decrease? How much exercise is cardioprotective? The
Nurses Health study and the Hawaiian Heart Study in measuring physical activity
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have determined that those with additional energy expenditures of 2000
kilocalories per week had fewer risk factors than the control subjects. This
physical activity was gained primarily through brisk walking 2.5 to 3 hours per
week or 1.5 miles per day. Even walking 1 hour per week lowered relative risk to
0.80.183
These energy expenditures were estimated using prediction equations
based on a healthy able-bodied population and during planned periods of
exercise. Can similar changes be induced in people who are physically disabled?
Is there an accurate method of quantifying activity not just during planned
exercise bouts but during free living?
The measurement of physical activity during free-living is difficult and
researchers continue to be plagued by imprecision of measurement techniques
available that avoid disruption of routine activities.124 Both physical fitness and
physical activity measurements can be used to define the health benefits of
exercise, but is there a better measurement available than VO2max or leisure
time physical activity that helps enhance the quantification of total energy
expenditure and/or physical activity?202 Is there a measure that better estimates
physical activity in relation to cardiovascular risk and markers of inflammation?
Uncertainty remains about the optimal patterns, duration and intensity of
physical activity necessary to minimize risk of CVD. When observing the
relationship between physical fitness and CVD, measurements of VO2max or
estimates of VO2max have been used. The assessment of VO2max requires
exercise to a maximal volitional exertion level and a high level of motivation by
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the subject.148 This measure is potentially dangerous often requiring an
automated external defibrillator and the presence of medical personnel.
Additionally, it is generally not well tolerated by sedentary individuals, those with
health problems and those at risk for cardiovascular disease.148 A method that
quantifies the capacity of an individual to exercise for longer periods of time is
more appropriate for the general population because people spend the majority
of their time in submaximal levels of activity.147 Currently there exists limited
information on ventilatory threshold and the risk factors of CVD.203 To date there
are no articles published on the relationship of ventilatory threshold to CRP and
CVD risk.
The question still remains as to the optimal intensity level necessary for
reduction of CVD risk. Measures of fitness can provide information on average
levels of activity but is the relationship of physical activity and CVD related more
to intensity of activity? Do periods of maximal activity have to be performed on a
regular basis or can moderate levels of exercise suffice?
Accelerometry assists with the measurement of physical activity during
“free living” with recordings of total activity, intensity and duration of bouts
available for extended time periods. Not much research exists on the use of
accelerometry to determine CV risk. Would it be possible to use CRP and
accelerometry to determine amount and intensity of PA to provide protection from
CV events?
Both accelerometers and VT measurements can provide assessment of
overall activity regardless of method of accumulation. Can these methods be
51

used in combination to better quantify total daily physical activity or energy
expenditure? Can these measurements be utilized in populations with physical
disability?
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CHAPTER 2
RESEARCH QUESTIONS

Main Question
How is physical activity related to systemic inflammation and the risk
factors of CVD?
Study I: Intervention study of healthy, sedentary adults
By changing the activity levels of a sample of sedentary individuals, can
systemic inflammation and the risk factors of CVD be lowered?
Is one method of promoting walking for health better than another and can
physical activity be increased in the sedentary?
Study II: Observation of a population cross section of healthy adults
What is the relationship of systemic inflammation and the CVD risk factors
to physical activity as measured by activity counts in a cross section of the
population?
Study III: Special Populations - survivors of stroke
How does a sample of the population three months or more after stroke
compare to age and gender matched sedentary controls in the risk factors of
heart disease?
How do daily activity levels of the above populations differ?
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CHAPTER 3
INCREASING PHYSICAL ACTIVITY AND REDUCING CARDIOVASCULAR
RISK USING METHODS OF ACCUMULATING PHYSICAL ACTIVITY

Abstract
Purposes: To determine effects of two activity accumulation methods on
increasing physical activity. To determine the effect of resultant physical activity
increases on expression of CVD risk factors and inflammation. Methods:
Fourteen volunteers ages 31-66 participated in a 10-week intervention.
Participants were assigned to group by availability. Groups were randomized to
10,000 steps or Active Living, Everyday.® Pre/post-intervention testing included
BMI, waist girth, blood pressure, C-reactive protein (CRP), fitness, cholesterol,
and blood glucose. Results: Both activity accumulation groups significantly
increased number of steps (p < 0.05) during the intervention period. No between
group differences were found in step count, CRP or CVD risk factors. Within
groups, significant changes in number of steps (95% CI: 4,126 to 1,179 steps per
day), estimated VO2max (95% CI: 5.22 to 1.18 ml/kg/min), waist circumference
(95% CI: 6.71 to 0.60 cm) and hemoglobin A1c (95% CI: -0.01 to -0.09 percent)
were observed. No significant changes were noted in CRP, blood pressure or
cholesterol. Conclusions: Both programs were equally effective in increasing
physical activity over 10 weeks. Increases in physical activity resulted in
improved fitness and blood glucose but were not sufficient to provide changes in
multiple heart disease risk factors or inflammation.
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Introduction
Cardiovascular disease (CVD) is the number one cause of death in the
United States and its incidence continues to rise.2, 204 Inflammation is related to
CVD and inflammatory markers have been suggested as indicators of
cardiovascular events such as stroke or heart attack.80 Physical inactivity has
been determined to be one of the primary risk factors for cardiovascular disease.
It is well known that there is an inverse relationship between physical activity and
cardiovascular disease. Routine physical activity decreases CVD4, 45 and its risk
factors5-9 and improves health.2
From the 1996 Surgeon General’s report it was estimated that in the
United States, more than 60% of adults are not regularly physically active and
25% are not active at all.2 Current physical activity recommendations from the
Centers for Disease Control (CDC) and the American College of Sports Medicine
(ACSM) are to accumulate 30 minutes of moderate level activity most if not all
days of the week with moderate level activity defined as the equivalent of a brisk
walk.56 Although it is clear that increased physical activity is associated with
improved health, the debate continues about the specifics of optimal physical
activity recommendations.205
There are many methods for an individual to increase their physical
activity from participation in competitive sports to a basic walking program.
Planned, structured physical activity (exercise) has been proven effective at
improving physical activity, fitness and health, unfortunately only small numbers
of Americans routinely engage in this type of physical activity and dropout rates
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are high.206 Because scheduling physical activity into a busy day is often difficult,
there is a need for alternatives to structured exercise to increase physical
activity.207
Rather than performing one 30 minute bout of continuous structured
physical activity, an alternative method of attaining the CDC/ACSM guidelines is
through the accumulation of physical activity. It has been suggested that the
accumulation of physical activity in multiple shorter bouts can provide
comparable increases in fitness as one continuous bout of similar total
duration.208
There are also programs that may allow the accumulation of physical
activity without any structured bouts of exercise. By incorporating physical activity
into one’s normal daily activities, one may eliminate the need for scheduling
physical activity sessions to achieve activity goals. This approach may increase
program participation and lower dropout rates. Active Living Everyday® (ALED)
and 10,000 steps are two examples of programs that encourage activity
accumulation. In these programs, physical activity accumulation is promoted
primarily through walking activities. Walking is a viable option for most individuals
and can be performed at minimal to no cost.
Several studies have examined the 10,000 steps per day target as a
method of meeting the current national physical activity guidelines.209-212 Other
studies have investigated the effect of lifestyle behavior change interventions
similar to ALED on increasing activity.213-215 Participants who exceed 10,000
steps are more likely to meet the current physical activity guidelines,216 but more
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research is necessary to examine the effectiveness of these programs on
increasing physical activity.
There have been many studies that have examined the relationship
between individual CVD risk factors and physical activity however, most have
used physical activity questionnaires to gauge physical activity accumulation.
Physical activity questionnaires are subjective and can have errors up to 50
percent.10, 11 The pedometer is a low cost, unobtrusive and easy to use
alternative to the questionnaire that provides objective monitoring of daily activity
levels.132, 134 Some health promotion programs, such as 10,000 steps and ALED,
encourage the use of pedometers to provide both feedback and goal-oriented
motivation to increase physical activity. There have been some studies on the
associations of pedometer-measured physical activity with some of the
established CVD risk factors,205, 206, 217-220 however, there are few studies on the
relationship between accumulated physical activity and multiple modifiable CVD
risk factors.206, 218
Furthermore, although inflammatory markers such as C-reactive protein
have been examined in epidemiological studies and in studies of athletes,112, 116118

no studies are known to these authors that have examined the effects of

accumulated moderate level physical activity on C-reactive protein levels. It is
unclear if the intensity and duration of physical activity recommended in these
programs is sufficient to lower markers of systemic inflammation and the risk
factors of heart disease. If activity accumulation programs do result in increased

57

activity levels, how is this increase in physical activity related to measures of
CVD risk?
The purpose of this study was twofold. 1. To determine the effects of two
methods of activity accumulation on increasing physical activity levels in those
not currently meeting physical activity guidelines. 2. To determine the effect of
the resultant increase in physical activity on the expression of CVD risk factors
and inflammatory markers. We hypothesize that both intervention methods will
be equally as effective in initiation of physical activity and that the resultant
increase in physical activity will have an effect on some, but not all, of the CVD
risk factors.
Methods
Informed written consent was obtained from all participants. All
procedures were approved by The University of Montana Institutional Review
Board for Use of Human Participants and conformed to the Declaration of
Helsinki. Eighteen subjects were initially recruited. Fourteen volunteers, 2 males
and 12 females, ages 31 - 66 completed the study.
The sample of convenience was obtained through flyers posted on a
university campus and through the employee well-check flyer. All participants
were tested on the same day and fasted for 12 hours before scheduled testing
time. As participants arrived, they were asked to complete a consent form and a
medical history questionnaire as well as a PAR-Q 221 to determine if participation
criteria were met. The criterion for physical activity was not meeting the daily
recommendation of 30 minutes of moderate activity. Exclusion criteria included
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individuals taking medications that would influence heart rate, blood pressure,
blood glucose or cholesterol, recent infection or surgery within the previous 3
months, previous heart disease or myocardial infarction.
Using standard techniques, resting blood pressure was taken in the
seated position with a mercury sphygmomanometer.222 Waist girth,223 resting
heart rate, weight and height were also measured. Blood samples were collected
in the morning after fasting for at least 12 hours before scheduled testing time.
Two 12 ml vials of venous blood were analyzed at a hospital laboratory for total
cholesterol (TC), low density lipoprotein cholesterol (LDL), high density
lipoprotein cholesterol (HDL), blood glucose (HbA1c) and the inflammatory
marker C-reactive protein (hs-CRP). Samples were analyzed for HbA1c, hs-CRP
and lipids enzymatically using an automated clinical chemistry analyzer (RocheHitachi P-module, Indianapolis, IN) with estimation calculation of LDL cholesterol
using the Friedewald equation.79
Fitness level was measured by the Reebok 1-mile walk test.223 The
participants were instructed to walk one mile as fast as possible around a premeasured 1/3 mile oval track. The elapsed time for the test was recorded and
heart rate was measured immediately after completing the 1 mile walk. Estimated
VO2max was calculated using the Reebok walk test prediction equation.223
At the completion of the testing, participants were issued a digital
pedometer (Walk for Life, Plainfield, IL) and instructed to wear it on the
waistband of their clothes every day whenever out of bed except when bathing.
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Participants wore the pedometer for 5 to 7 days prior to the first intervention
meeting to determine baseline physical activity.
Although intervention type was randomly assigned to the 2 groups,
participants were placed into groups of convenience according to group meeting
time. Equal numbers of males and females were assigned to each group. Group
1 participated in an educational lifestyle behavior change program, ALED,224 in
which physical activity was encouraged throughout the day. Group 2, 10,000
steps, was a goal-oriented walking group encouraged to attain 10,000 steps
daily. Both groups met weekly for one hour to standardize contact time.
Intervention
The intervention phase consisted of each group meeting one hour per
week for a total of 10 weeks. All participants were asked not to change their
dietary behaviors during the study period. Each week, attendance was taken and
the investigators recorded the pedometer data for each participant in both
groups.
During these meetings, group 1 attended an ALED class promoting
lifestyle behavioral change. Active Living Everyday® is an educational program
that uses social cognitive theory and the transtheoretical model (stages of
change) to encourage behavior change towards an active lifestyle.225 This class
is offered through Human Kinetics (Champaign, IL) and each of the participants
in the group received a workbook and a log to record daily physical activity.224
This program encourages an increase in walking whenever possible throughout
the day to accumulate a total of at least 30 minutes of moderate intensity activity.
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Each module provides education on topics related to increasing activity and
readiness for change is assessed periodically throughout the program. See table
1 for examples of topics covered in the ALED course. A group facilitator trained
by Human Kinetics worked with participants following the modules in the
workbook. These interactive lessons encourage problem solving to introduce
techniques and strategies that can be individualized to assist in achieving a more
active lifestyle. Some modules were accelerated or combined to tailor the
program to the group and because some of the topics such as pedometer use,
the one-mile walk and self-monitoring of heart rate were covered during the pretest session. No structured exercise was performed during these group meetings
although physical activity was occasionally incorporated to emphasize major
points such as learning how to perform a walking test.
Group 2 followed the traditional 10,000 steps walking program. The
10,000 steps program is a widely advocated method of increasing physical
activity originally created by Yoshiro Hatano (1993) in Japan.209 The goal of this
program is to gradually increase the total number of steps taken in one day to
10,000 and to maintain or exceed this level of accumulating 10,000 steps
everyday. The only instructions to participants were to increase their walking
opportunities whenever possible throughout the day and to gradually increase
number of steps until 10,000 steps was reached or exceeded. This group
participated in a weekly meeting lasting one hour. During this meeting,
attendance was taken, pedometer readings were recorded and a group walking
session was offered. No formal instruction occurred during these sessions. The
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Table 1
Topics Covered in the Active Living, Everyday® Program
Intensity and
Increasing activity

Goal setting

Stress
duration

Time

Balancing

Using

management

calories

pedometers

Previous success

Benefits of

Measuring heart
Positive changes

Avoiding pitfalls

activity

rate
Stretching

Barriers

Walking test

Problem solving

exercises
Support
New activities

Lasting changes

Self reward
enlistment

Table 1: Topics covered in the educational program that uses social cognitive
theory and the transtheoretical model to encourage changes in behavior and an
active lifestyle.
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Table 2
Baseline Descriptive Data
ALED

10,000 steps

Age (yrs)

45.71 + 8.65

51.29 + 7.74

Height (m)

65.14 + 2.13

66.25 + 3.76

Weight (kg)

76.10 + 17.88

79.89 + 8.95

Daily Step Count

6,788 + 2,492

6,591 + 1,884

BMI (kg/m2)

27.54 + 5.34

28.22 + 3.81

Waist girth (cm)

82.86 + 13.87

84.31 + 9.95

SBP (mmHg)

111.14 + 18.07

114.67 + 12.37

DBP (mmHg)

76.00 + 8.08

78.50 + 9.46

Baseline descriptive data for accumulated activity groups Active Living,
Everyday® and 10,000 steps groups. Yrs = years, m= meters, kg = kilograms.
BMI = body mass index, cm = centimeters, SBP = systolic blood pressure,
mmHg = millimeters of mercury, DBP = diastolic blood pressure
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primary purpose of this meeting was to record pedometer readings and to
standardize contact time with participants between the 2 groups. After ten group
sessions were completed, all participants were retested in the same manner as
the pretesting.
Data Analysis
T-tests were performed to analyze differences between groups in age and
attendance. Repeated measures analysis of variance was used to assess
differences over time between the ALED and 10,000 steps intervention groups
for the following dependent variables: cholesterol (TC, HDL, LDL), HbA1c, blood
pressure, CRP, BMI, waist girth, steps per day, and estimated VO2max.
Significance levels were set at p < 0.05.
Results
Initial enrollment in the study was 18 however one participant underwent
shoulder surgery, two were unable to attend the post testing and one withdrew
due to personal issues. Two males and 12 females, 1 male and 6 females in
each group, completed the 10-week intervention. Descriptive variables are listed
in table 2. There were no significant differences between the groups. Average
age of subjects was 48.5 + 9.2 years. Baseline step counts were 6,591 + 1,884
steps for the 10,000 steps group and 6,788 + 2,492 steps for the ALED group.
Average weekly step counts for each group are depicted in figure 2. Both groups
significantly increased their step count with 10,000 steps increasing to as high as
10,334 + 2,037 steps per day and ALED increasing to as high as 9,943 + 2,308
steps per day during the intervention period. The mean step count at the end of
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Figure 2

Average Steps per Week by Group

Average Step Count

10000

8000

6000
Baseline

Week 2

Week 4

Week 6

10,000 Steps

Week 8

Week 10

ALED

Figure 2: Changes in the average number of steps per day by group as
measured by pedometer over the ten week intervention period. ALED = Active
Living, Everyday.®
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the 10 weeks was 9,892 + 3,690 for 10,000 steps and 9,056 + 2,348 for the
ALED group. Weekly meeting attendance was significantly less in the walking
group than the ALED group (p < 0.05 level) with attendance averaging 54.3% for
10,000 steps and 72.5% for ALED. There were no differences between groups
found for any of the dependent variables of interest (step count, CVD risk factors
or CRP). Because none of these dependent variables significantly differed
between the ALED and 10,000 steps treatment groups, the results for all
participants were combined and analyzed together as one group.
Results for all subjects are listed in table 3. There were significant
changes in number of steps (95% confidence interval: 4,126 to 1,179 steps per
day). Significant changes were also observed in estimated VO2max (95%
confidence interval: 5.22 to 1.18 ml/kg/min), waist circumference (95%
confidence interval: 6.71 to 0.60 cm) and hemoglobin A1c (95% confidence
interval: -0.01 to -0.09 percent). Physical activity increased by 2,704 steps or
43%, from a baseline of 6,690 + 2,125 to an average of 9,542 + 2,922 steps per
day. By the end of the 10 weeks, 4 participants (29%) exceeded 10,000 steps
and 83% of participants increased physical activity levels. Increases in VO2max
were 3.2 ml/kg/min or 11% and decreases in HbA1c was from 5.19 to 5.14 or 1%
over the 10 week period. There were no significant changes in BMI, CRP, blood
pressure or cholesterol levels.
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Table 3

Results: All Subjects
Baseline

10 weeks

Daily Step Count

6,690.00 + 2,125

9,541.99 + 2,922*

BMI (kg/m2)

28.58 + 4.97

28.42 + 4.57

Waist girth (cm)

85.17 + 13.29

88.82 + 10.66*

SBP (mmHg)

116.29 + 19.64

117.14 + 16.78

DBP (mmHg)

77.36 + 8.167

77.57 + 9.52

est VO2max (ml/kg/min)

29.00 + 9.61

32.20 + 10.01*

HbA1c (%)

5.19 + 0.15

5.14 + 0.15*

Total Cholesterol (mg/dl)

206.50 + 33.80

205.21 + 36.59

Triglycerides (mg/dl)

144.50 + 108.20

137.43 + 76.21

HDL (mg/dl)

61.71 + 16.14

62.71 + 14.90

LDL (mg/dl)

118.29 + 29.12

115.00 + 28.40

CRP (mg/dl)

0.21+ 0.18

0.20 + 0.15

Table 3: Dependent variable results of pre- and post-testing for all subjects. *
indicates statistically significant differences at p = 0.05. BMI = body mass index,
kg = kilograms m2 = meters squared. cm = centimeters, SBP = systolic blood
pressure, DBP = diastolic blood pressure, mmHg = millimeters of mercury, est
VO2max = estimated maximum volume of oxygen consumed, HbA1c =
glycosylated hemoglobin, mg = milligrams, dl = deciliter, HDL = high density
lipoprotein cholesterol, LDL = low density lipoprotein cholesterol, CRP = Creactive protein.
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Discussion
Because of the low adherence levels to structured exercise programs,207 it
is important to find alternate means of increasing physical activity in the general
population. When activity can be incorporated into daily routine, it becomes more
appealing and less intimidating.226 Adherence to activity programs has improved
when activity accumulation methods have been utilized.227, 228
Both the ALED and 10,000 steps programs promote the integration of activity into
daily living and in this study resulted in similar outcomes after 10 weeks of
intervention. Our results support the findings of previous research. Both the
ALED and 10,000 steps groups were effective in increasing physical activity, as
measured by average daily step count, with neither method more effective than
the other.
By incorporating a gradual, moderate approach to increasing physical
activity into daily routine, daily energy expenditure215 and fitness227, 228 have been
increased. In the current study, attained increases in physical activity, as
measured by step count, resulted in increased physical fitness as measured by
estimated VO2max. In addition, 29% of our subjects, two from each group,
exceeded 10,000 steps by the end of the 10 weeks. These results are similar to
previous research. In a study of Japanese workers, 42% of participants
exceeded the 10,000 steps for 4 weeks but only 11% exceeded for 12 weeks.219
When the participants were grouped together in the current study,
baseline step counts were 6,690 + 2,125. In a study of people with type 2
diabetes mellitus by Ariaza et al., baseline data was similar to the current study
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with the control group baseline at 6,239 ± 2,985 and the active group baseline at
7,220 ± 2,792 steps per day. Baseline counts in other pedometer studies ranged
from a low of 4,491 up to a high of 5,753 steps per day.205, 206, 217, 219 With the
exception of the Ariaza study, other activity accumulation studies began with
participants who were less active than those in the current study.218
Resultant physical activity after 10 weeks was similar to 2 other participant
groups. The final step count of 9,542 steps attained in the current study were
comparable to the steps attained in a 12 week study by Tudor-Locke et al.217 of
9,123 steps and in an 8 week study by Swartz et al.206 of 9,213 steps. Changes
in activity in these studies were 3,737 steps or 37% and 4,722 steps or 51%
respectively. Physical activity increased by 43% in the current study. Other
studies using 10,000 steps as a goal resulted in higher daily step counts.
Hultquist et al. recorded step counts of 10,410 and Ariaza et al. observed
increases to 10,159 steps. Hultquist et al. recorded an increase of 4,807 or 46%
in a 4 week observation,205 and Ariaza et al. observed an increase of 2,939 steps
or 29% in 6 weeks.218 The studies by Swartz et al. and Hulquist et al. resulted in
the greatest increases in physical activity.
In the current study, significant changes in CVD risk factors were
observed in glycosylated hemoglobin as measured by HbA1c and fitness level as
measured by estimated VO2max. No significant changes in blood cholesterol
levels or blood pressure were observed. A reduction in average blood glucose
levels occurred in the current study by increasing step counts by as little as 2,704
steps per day over 10 weeks. However, significant decreases in other CVD risk
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factors such as blood pressure or cholesterol did not occur (see table 3). Other
studies that have assessed the effect of the 10,000 steps program on CVD risk
factors have had both similar and conflicting results.205, 206, 219
In studies of activity accumulation, the most commonly utilized blood
glucose measurements have been fasting blood glucose and HbA1c. Glucose
tolerance tests also provide valuable information on impaired glucose
metabolism. Levels of HbA1c dropped 1%, from 5.19 to 5.14 in our study. This is
a clinically significant change and comparable to other intervention studies of
sedentary participants where education on physical activity was provided and
activity increases were voluntary. In these studies, levels of HbA1c decreased by
0.8, and 0.6%.229-231 When examining other studies that used the 10,000 steps
intervention, no change in HbA1c was observed after interventions of 6 and 12
weeks in length.218, 219 In a 10,000 steps study, Swartz et al. monitored blood
sugar levels with fasting blood glucose and 2-hour glucose tolerance rather than
HbA1c. In this 8 week study of people with type 2 diabetes, statistically significant
improvements were found in 2-hour glucose tolerance but not in fasting blood
glucose.206 Other activity accumulation studies did not assess blood glucose.205,
225

The 1% decrease in average blood glucose levels we observed is a positive

change towards lowering CVD risk.
In the current study, increases in VO2max and waist circumference were
observed however no significant changes were found in BMI. Increases in
VO2max were 3.2 ml/kg/min in the current study. This finding is consistent with a
meta-analysis of walking interventions in which significant increases in VO2max
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of 3.6 + 0.5 ml/kg/min were obtained without statistically significant changes
occurring in either BMI or percent body fat.232 Our findings are in agreement with
previous studies using activity accumulation where despite improvements in
physical activity and/or fitness, no improvements in obesity measures were
observed.205, 206, 218, 219
Accumulation of activity over time may be sufficient to produce changes in
fitness but not decreases in BMI or other CVD risk factors. As in our study, no
improvements in LDL cholesterol or HDL cholesterol, BMI or weight were seen in
the previously mentioned activity accumulation studies. As stated in our
hypothesis, we did not expect changes in all of the CVD risk factors. To obtain
greater improvements in CVD risk factors, higher intensity activity may be
necessary than that needed for improvement in fitness.223 Higher intensity
aerobic dance, compared with low-intensity walking was more effective in
improving CVD risk factors.233 In general, stronger associations of CVD risk
factors have been found with higher intensity activities.234
One of the factors that may result in the greatest changes in CVD risk
factors is weight loss because obesity is linked to many of the CVD risk
factors.235 Even modest weight loss has resulted in decreased fat mass, blood
pressure, blood glucose, low-density lipoprotein, and triglyceride levels.236
Weight loss can be achieved by increasing physical activity or decreasing dietary
intake. Improving both physical activity and diet may provide the greatest weight
loss. Despite the benefit of changing both diet and physical activity, we wanted to
focus on the effects of physical activity on CVD risk factors. Therefore, we
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controlled for dietary influences by asking participants to maintain their dietary
habits. The activity accumulation programs used in the current study did not
result in weight loss. It is likely that either dietary changes or a greater physical
activity intensity level is necessary for weight decreases to occur.
The effects of activity accumulation on changes in blood pressure have
also been varied. Our study is consistent with 2 other studies in that blood
pressures did not significantly change from initial measurements.218, 219 The
mean systolic blood pressure in our study was 116.3 + 19.6 mmHg and the mean
diastolic blood pressure was 77.4 + 8.2 mmHg. Two other studies using 10,000
steps interventions, Hulquist et al. and Swartz et al., observed significant
decreases in blood pressure.205, 206 Changes in physical activity (as measured
by change in step counts of 4,722 and 4,807 steps) were greater in these 2
studies than the other activity accumulation studies. In comparison, the increase
in step count in the current study was 2,704 and in the Ariaza et al. study was
2,939 steps. It may be that greater changes in physical activity may be necessary
to affect changes in blood pressure.
The systemic inflammatory marker C-reactive protein (CRP) has been
suggested as an indicator of CVD risk. In general, there appears to be an inverse
relationship between physical activity and CRP levels.47, 104, 107 However, CRP
has not yet been established as a predictor of CVD events in the general
population. Some researchers have noted decreases in levels of CRP in athletes
with regular training48, 99 but the results have not been consistent across
sports.108, 120 We did not observe any significant changes in CRP levels after the
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10-week intervention in our sample of the population. The baseline values we
observed were similar to that of other research,48, 99, 108, 120 however, we
observed a high variation within and among participants. Within subject variation
of CRP is 4 to 6 x greater than that of cholesterol.100 Baseline levels of CRP are
known to fluctuate up to 60% and this variation of CRP makes it difficult to use in
all but epidemiological studies with large numbers.100
Accumulated physical activity can provide increases in fitness and
physical activity. Programs such as 10,000 steps and ALED provide alternatives
that are less intimidating to those who have not previously exercised. This
approach to physical activity may allow for improvement in success rates and
decreases in drop-out rates that are so apparent in structured activity programs.
Because physical activity can be incorporated into a busy day, accumulation
programs may increase adherence and provide opportunities for successfully
increasing physical activity. The focus of these activity accumulation programs is
to increase opportunities for physical activity and provide a vehicle for
participants to increase total activity. This is an important step, to promote
lifestyle changes and begin the journey towards being physically active.
However, it may be necessary to provide additional guidance on activity
parameters, particularly intensity.
Positive changes in some CVD risk factors occurred with accumulated
walking programs after 10 weeks in the current study and after 4 – 12 weeks in
other similar studies.205, 206, 219 Effecting decreases in other CVD risk factors may
require a minimal intensity or higher activity accumulation. Researchers suggest
73

that the total amount of moderate level physical activity accumulated, regardless
of accumulation method, is important for health benefits.237 Participants who
accumulated 10,000 steps per day were more likely to meet the current physical
activity guidelines but accumulation of 10,000 steps did not guarantee
success.216 The challenge of using activity accumulation programs to increase
physical activity is that activity intensity is generally not emphasized. Hatano
(1993) stressed the importance of walking intensity at a “fairly fast pace” in his
10,000 steps program.209 However, emphasis on intensity of physical activity has
been lost in the public promotion of this program within the United States.
Intensity is an important component for reduction of CVD risk. To more effectively
reduce multiple CVD risk factors, accumulated activity programs may need to
incorporate a focus on incremental increases in activity intensity as well as
activity accumulation.
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CHAPTER 4
EXPLORING THE RELATIONSHIP BETWEEN CARDIOVASCULAR DISEASE
RISK AND PHYSICAL ACTIVITY AS MEASURED BY ACCELEROMETERS

Abstract
Purpose: The purpose of this study was to explore the inverse relationship
between global CV risk scores and PA. A secondary purpose was to determine
the PA intensity and duration best associated with reduced CV risk.
Cardiovascular disease (CVD) accounts for 37.1 percent of all deaths in the
United States.238 Many of these deaths are preventable with reduction in
sedentary behaviors. Using individual independent risk factors for CVD, global
CV risk scores like the Framingham have been developed to predict individual
CVD risk. Although sedentary lifestyle has been identified as 1 of the 8 known
risk factors for CVD, no known global risk scores include measures of physical
inactivity. The exclusion of physical inactivity in CV risk scores is attributed to the
difficulty in reliably quantifying physical activity (PA) levels of individuals. There is
a need to better quantify habitual PA and to include PA in global risk
assessment. Methods: Forty five males and 65 females completed this study.
Weight, height, resting blood pressure, waist girth and skinfold measurements
were taken. Body mass index (BMI) was calculated. An accelerometer was worn
on the right hip for 7 full days including a weekend period. A blood sample was
analyzed for total cholesterol (TC), low density lipoprotein cholesterol (LDL), high
density lipoprotein cholesterol (HDL), triglycerides, and glycosylated hemoglobin
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(HbA1c). Based on established values for each gender, absolute risk ranks were
developed for systolic and diastolic blood pressure, total cholesterol, HDL
cholesterol and LDL cholesterol, percent body fat and waist girth, and
glycosylated hemoglobin (HbA1c). To obtain global CV risk ranks, absolute risk
ranks were summated for each individual. Habitual PA was examined using
multiple methods. Activity was divided into sedentary, light, moderate and
vigorous levels to examine intensity. To consider duration, time spent in each
category was examined. To further explore intensity, individual minutes of
highest intensity achieved for each day were examined for durations of 5 minutes
(hct5) up to 120 minutes (hct120) in 5 to 15 minute increments. Total activity and
average counts per minute per day were also determined. T-tests analyses were
used to determine differences between genders and one-way ANOVAs were
used to evaluate age group differences for minutes of activity at various intensity
levels. Pearson correlations between CV risk scores and PA patterns were
calculated. The 2 PA methods with highest correlations to CV risk scores were
then used in a multiple regression analysis with age and by gender to develop
prediction scores for CV risk. Statistical significance was set at p < 0.05. Results:
Of the participants in our study, 67% met or exceeded the recommended minimal
PA guidelines of 30 minutes of moderate PA 5 of 7 days per week and 45% met
these guidelines 6 of 7 days per week. Overall, participants spent 73% of time in
sedentary activities, 19.6% in light activity, 5.5% in moderate activity and 1.8% in
vigorous activity. The best fit regression line of CV risk score for men was with
total daily activity and age (r = - 0.53, standard error of the estimate (SEE) =
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0.58). For women, hct30 and age had the best fit (r = -0.44, SEE = 0.50). When
analyzed by age group, the best fit line for group 1 (ages 18-24) was with hct5, r
= -0.45, SEE = 0.40 and the best fit line for group 2 (ages 25-44) was with total
counts, r = - 0.41 and the SEE = 0.71. No significant regression line was found
for Group 3 (ages 45-65) but total counts provided the best fit line at r = -0.33,
SEE =0.53, p = 0.06. Conclusion: Total daily activity and total time in moderate
activity were inversely related to CVD risk. However, reaching higher intensity
levels for 1 minute periods accumulated for at least 5 minutes a day appears to
be better related to lower risk of CVD than longer durations of moderate or
vigorous activity per day, particularly at younger ages.
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Introduction
Physical activity (PA) has long been associated with health benefits.2 As
early as 1979, the Framingham study identified physical inactivity to be related to
cardiovascular disease (CVD) mortality and morbidity.239 In 1992, physical
inactivity was recognized as a fourth major risk factor for coronary heart disease
by the American Heart Association.240 There are currently a total of 8 risk factors
for CVD. They include age, family history, smoking, hypertension, dyslipidemia,
physical inactivity, diabetes and obesity.2 From these individual independent risk
factors, equations have been developed to determine overall or global CV risk
scores (eg. Framingham, Modified Sheffield, New Zealand, Joint British
Recommendations). The Framingham risk equation is the “gold standard” and
includes gender, total cholesterol, high density lipoprotein cholesterol (HDL),
blood pressure, age, and smoking in the calculations.241 The original
Framingham equation also included left ventricular hypertrophy.242 Other risk
estimates such as the modified Sheffield, the Joint British and New Zealand add
diabetes to improve on sensitivity and specificity. Unfortunately, none of these
global risk equations include physical inactivity. The exclusion of physical
inactivity in CV risk scores is attributed to the difficulty in reliably quantifying PA
levels of individuals.
Habitual PA has been difficult to measure without high cost or imposition
upon free living. The two standards for PA measurement that have been most
practical for large scale studies have been self-report and cardiorespiratory
fitness (fitness).124, 243 Discrepancies regarding intensity level are common when
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using self reported activities, with estimated error ranging from 35 to 50 percent
depending on individual recall and perception of activities.10, 11 Large cohort
studies have found fitness, as measured by VO2max, to be inversely related to
all-cause and CVD mortality.128, 130 However, fitness testing provides information
about maximal exercise capacity without details regarding habitual activity
patterns. There is a need to better quantify habitual PA and to improve our
understanding of the relationship between PA and CVD.
Technological advances have allowed for objective measurement of
habitual PA through the use of accelerometers. Accelerometers are motion
sensors that provide a description of free-living PA in real time including intensity,
duration and frequency. These devices can record and store data for extended
periods of time. There have been several studies using accelerometers
individually relating the single risk factors of obesity,244-246 cholesterol140 and
blood pressure247 to habitual PA. The majority of this bivariate research has
analyzed PA using total activity counts. There exist no studies known to this
author that relate a global CV risk score to PA.
The purpose of this study was to explore the inverse relationship between
global CV risk scores and PA. A secondary purpose was to determine the PA
intensity and duration best associated with reduced CV risk.
Methods
Eligible participants were apparently healthy males and females between
18 and 65 years old. Individuals taking medications that would influence heart
rate, blood pressure, blood sugar or cholesterol, with recent infection or surgery
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within the previous 3 months, or those with previous heart disease or myocardial
infarction were excluded from the study. Informed written consent was obtained
from all subjects with all procedures approved by the Institutional Review Board
at The University of Montana.
A sample of convenience was obtained primarily through word of mouth
from the local area population. An attempt was made to obtain a fair
representation of young (18-24), middle (25-44) and older (45-65) age ranges,
both male and female genders and both active (fit) and sedentary (unfit)
individuals. One hundred forty subjects (65 males, 75 females) volunteered for
this study, completed a fasted blood draw, performed exercise testing and wore
an accelerometer for a week. Complete data were present for 110 subjects (45
males, 65 females) who were used for this analysis.
When participants arrived for their testing session, they were asked to
complete a consent form, a medical history questionnaire and a PAR-Q221 to
determine if participation criteria were met. After sitting quietly for 5 minutes,
resting heart rate was observed and resting blood pressures were taken using
the procedures recommended by the American Heart Association.222 Weight and
height were measured and recorded and from these measurements body mass
index (BMI) was calculated.223 Waist girth and skinfold measurements were
taken per American College of Sports Medicine (ACSM) recommended
protocols.223 Using the gender specific three-site protocol, skinfold measures
were converted into percent body fat using the ACSM recommended JacksonPollock equations.223
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At the completion of the above testing, participants were fitted with an
Actical accelerometer (Minimiter, Bend, Oregon). The Actical activity monitors
are small (2.8 x 2.7 x 1.0 cm3), lightweight (17g) units that have a primary plane
of detection but are sensitive to all three planes of motion. The Actical is a piezoelectric accelerometer with a range of 0.5 to 2G and frequency of 0.35 to 3.5 Hz.
The Actical samples acceleration at a rate of 32 Hz and integrates this over the
user-defined epoch.248 In this study, the epoch was set at 1 minute, comprising a
total of 1440 measurements for each day. The accelerometer was worn on the
right hip for 7 full days including a weekend period. Participants were asked to
wear it every day whenever out of bed except when bathing. Log sheets were
provided to record any activities such as motorcycle riding or snowmobiling that
might overestimate activity and any times where they neglected to wear the
device. Previous research has shown that in adults, a minimum of 3 to 5 days of
monitoring is optimal to determine activity patterns.140, 142 Monitoring for 7 days
was chosen to ensure inclusion of both weekday and weekend as conflicting
evidence exists regarding differences between weekday and weekend habitual
activity patterns.140, 249 Placing a single device on the hip or lower back is
recommended by Trost et al. in a review of accelerometer studies.142
A blood sample was collected from the participants within 2 weeks of the
testing session detailed above. Participants were asked to fast for 12 hours prior
to blood sample collection. Two 12ml vials of venous blood were drawn and
analyzed at a hospital laboratory for lipids [total cholesterol (TC), low density
lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL),
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triglycerides], and glycosylated hemoglobin (HbA1c) to measure average blood
glucose. Samples were analyzed for HbA1c and lipids enzymatically using an
automated clinical chemistry analyzer (Roche-Hitachi P-module, Indianapolis, IN)
with estimation calculation of LDL cholesterol using the Friedewald equation.79
Data Analysis
When activity monitors were returned, the data were downloaded into a
computer data file. Using the activity log sheets completed by the participant,
data for time periods that might overestimate activity such as snowmobile riding
or driving a truck on a dirt or bumpy road were eliminated. Also, all Actical files
were screened for periods of zero activity. If the Actical was not worn, per report
on the activity log sheet, this data was removed from the analysis.
Cardiovascular Disease Risk Calculation
Our primary objective was to investigate whether the clustering of risk
factors was related to habitual PA in a population sample of adults aged 18-65.
To compute CV risk ranks, an absolute rank was developed based on
established values for each gender for systolic and diastolic blood pressure,250
total cholesterol, HDL cholesterol and LDL cholesterol,251 percent body fat252 and
waist girth,253, 254 and glycosylated hemoglobin (HbA1c).254 The values used are
listed in table 4. For risk factors directly related to CVD such as systolic blood
pressure, ranks were calculated as the recorded value divided by 130, the
established cutoff value for hypertension. A person with systolic blood pressure
of 120 would receive a rank of 120/130 or 0.92 while someone at 140 would
receive a score of 140/130 or 1.08. For risk factors indirectly related to CVD such
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as HDL, for a male with an HDL score of 50, absolute risk was calculated as 1(50/40) or -0.25.
Once ranks were calculated for all individual risk factors, these ranks were
summated to obtain an absolute global risk rank for each individual. Several
different global risk equations were explored based on the measured CV risk
factors and are listed in table 5. For the purpose of this study, global risk
equations were selected that incorporated a majority of the modifiable risk
factors. Smoking was not included in the CV risk score calculations because so
few smokers volunteered for the study. Absolute risk A was calculated by
summation of the absolute ranks of 7 factors: average blood glucose (HbA1c),
systolic and diastolic blood pressure, LDL cholesterol, HDL cholesterol, waist
girth, and body fat. Absolute risk B substitutes total cholesterol for LDL
cholesterol and Absolute risk C, a non-obesity CV risk score, omits the waist girth
and body fat absolute risk scores from the calculations.
Patterns of Activity
A purpose of this study was to examine various parameters of PA which
might be best related to global risk for CVD. To evaluate this question, multiple
methods of looking at daily PA were produced from the raw accelerometer data.
Prior accelerometer studies have used total activity counts and duration of
moderate and vigorous activity to investigate PA patterns.140, 249 Since previous
studies suggest a minimum of 3-5 days to provide an accurate representation of
habitual physical activity,140, 142 at least 5 days of accelerometer data were
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Table 4
Established Risk Values By Gender
Males

Females

Percent Fat

25%

30%

Systolic Blood Pressure

130 mmHg

130 mmHg

Diastolic Blood Pressure

85 mmHg

85 mmHg

LDL

130 mg/dl

130 mg/dl

HDL

40 mg/dl

50 mg/dl

Total Cholesterol

200 mg/dl

200 mg/dl

Waist girth

101.6 cm

88.9 cm

HbA1c

7%

7%

Table 4: Established values indicating increased risk for each of the measured
parameters separated by gender. % = percent, mmHg= pressure in millimeters of
mercury, LDL = Low density lipoprotein, HDL = high density lipoprotein, mg =
milligrams, dL= deciliter, cm = centimeter.
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Table 5
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required to qualify for analysis in the current study. In order to examine PA
parameters, total counts per day (TAC) and average counts per minute per day
were determined first. Next, to examine intensity, activity was divided into
sedentary, light, moderate and vigorous. To examine duration, time spent in each
category was considered. Minute-by-minute PA counts were separated into these
categories according to their estimated PA energy expenditure expressed in
metabolic equivalents or METs and were defined from previous research of
Heil.255 Sedentary was considered activities of less than 1 MET (0-99 cts/min).
Light activities included activities of 1.1-2.9 METs (100-1500 cts/min). Moderate
activities required activities of 3-6 METs (1500-6500 cts/min) and activities that
were greater than 6 METs were considered vigorous (greater than 6500
cts/min).56
Once the intensity levels were calculated, multiple methods of viewing
activity were developed including average non sedentary counts, total counts in
each category, counts per minute in each category, and duration in single
minutes per day at various intensity levels. Since the current PA
recommendations are for accumulation of activity in bouts of 5 minutes or more,2
analysis included average counts and total time in moderate (Tmod) and
vigorous (Tvig) activity accumulated in 5 minute bouts or greater. To further
explore the effect of intensity, the individual minutes of highest intensity achieved
for each day were located. Then the highest counts per minute achieved for
durations of 5 minutes (hct5) up to 120 minutes (hct 120) in 5 to 15 minute
increments were observed. Again, these were the single minutes of highest
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intensity or the minutes which had the highest number of counts per minute.
Activity was analyzed as an average for all days and then further analyzed as
average weekends and weekdays separately because previous research had
suggested that there may be differences in activity patterns during the week and
on weekends.140, 249
Statistics
Means and standard deviations of descriptive variable and each risk factor
were calculated within each age group. T-tests analyses were used to determine
gender differences and one-way ANOVAs were used to evaluate age group
differences for minutes of activity at various intensity levels. T-tests were also
performed to examine differences in activity patterns between weekend and
weekday activity. Variables used for the weekend – weekday analysis were time
spent in each intensity level (sedentary, light, moderate and vigorous) overall and
by age group. A p value of less than 0.05 was considered to be statistically
significant.
Pearson correlations between the global CV risk scores and PA patterns
were calculated to determine which CV risk score had the highest correlations to
PA. The 2 PA methods with highest correlations to CV risk scores were then
used in a multiple regression analysis with age and by gender to develop
prediction scores for CV risk. Correlations of PA methods with CV risk were also
performed by gender for each of the three age categories. SPSS 12.0 (SPSS,
Inc., Chicago, Illinois) was used for all data analyses. To adjust for multiple
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comparisons in the correlational analyses, a p value of less than 0.001 was
considered statistically significant.
Results
Forty five males and 65 females had complete data sets and were used in
the data analysis. Age of subjects ranged from 18 to 64 with mean age of 34.6 +
13.8 years. The body mass index (BMI) of subjects ranged from 18.2 to 44.2
kg/m2. Minimum, maximum and means + standard deviations of descriptive
variables and individual CV risk factors for each age group are displayed in table
6.
Of the participants in our study, 67% met or exceeded 30 minutes of
moderate PA 5 of 7 days per week and 45% met these guidelines 6 of the 7 days
per week. Sample averages were 73% of time in sedentary activities, 19.6% in
light activity, 5.5% in moderate activity and 1.8% in vigorous activity. There was
no statistical difference found between weekdays and weekend days in time
spent in each intensity category. Time spent in sedentary, light, moderate and
vigorous activity for weekends, weekdays and all days are displayed in table 7.
When PA was analyzed by gender (table 8), men and women did not
significantly differ in amount of sedentary (1061.6 minutes + 90.8 versus 1066.3
+ 95.9 minutes), light activity (285.2 + 74.1 minutes versus 294.1 + 76.4
minutes), moderate activity (85.7 minutes + 44.2 men and 70.4 + 41.7 women)
and vigorous activity (7.5 minutes + 6.6 men and 9.2 minutes + 10.0 women).
Subjects were also analyzed by age category (table 8). Moderate and vigorous
activity time was highest in the youngest age group and decreased with
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Table 6

Height (m)

Weight (kg)

Percent body
fat (%)

Systolic
BP(mmHg)

Diastolic BP
(mmHg)
LDL (mg/dl)

HDL (mg/dl)

HbA1c (%)

Waist girth
(cm)

Descriptive Statistics By Age
Mean

Standard
Deviation

Minimum

Maximum

Younger

1.70

0.10

1.48

1.91

Middle

1.70

0.08

1.57

1.90

Older

1.71

0.08

1.58

1.98

Younger

67.83

11.51

48.75

95.20

Middle

77.90

20.52

54.15

140.30

Older

77.78

15.47

45.70

106.80

Younger

19.23

8.17

5.14

40.21

Middle

24.82

9.78

9.44

44.34

Older

29.98

7.70

15.10

41.90

Younger

118.20

7.81

102.00

134.00

Middle

123.12

16.16

91.00

168.00

Older

122.09

12.49

94.00

150.00

Younger

73.59

6.55

58.00

88.00

Middle

79.55

11.84

49.00

118.00

Older

79.73

10.56

59.00

108.00

Younger

88.64

22.57

43.00

154.00

Middle

83.48

28.43

20.00

135.00

Older

103.52

25.11

44.00

161.00

Younger

63.64

17.33

36.00

127.00

Middle

62.39

18.06

33.00

95.00

Older

67.79

16.93

41.00

111.00

Younger

5.04

0.23

4.60

5.50

Middle

5.16

0.24

4.80

5.90

Older

5.14

0.23

4.50

5.60

Younger

81.92

7.80

67.80

112.40

Middle

92.09

17.23

65.25

138.75

Older

94.32

13.11

67.58

112.00
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Table 6: Descriptive statistics separated into 3 age categories. Younger = 18-24
years old, Middle = 25 – 44, Older = 45 – 65, m = meters, kg = kilograms, % =
percent, BP = blood pressure, mmHg = pressure in millimeters of mercury, LDL =
low density lipoprotein, mg = milligrams, dL = deciliter, HDL = high density
lipoprotein, HbA1c = glycosylated hemoglobin, cm = centimeter.

Table 7
Percent Time in Each Activity Intensity By Day of Week
Activity Level

All days

Vigorous

Moderate

Light

Sedentary

Time
(min)

8.6

76.7

290.2

1064.3

std dev

9.9

38.1

74.0

93.9

% of day

1%

5%

20%

74%

1%

3%

5%

7%

9.7

80.5

286.3

1063.3

std dev

11.9

42.4

82.4

106.2

% of day

1%

6%

20%

74%

1%

3%

6%

7%

7.9

69.9

299.0

1063.0

std dev

13.2

42.5

96.7

114.9

% of day

1%

5%

21%

74%

std dev
%

1%

3%

7%

8%

std dev
%
Time
(min)
Weekdays

std dev
%
Time
(min)
Weekend
days

Table 7: Comparison weekday versus weekend of time and percentage of day
spent in each level of activity intensity. min = minutes, std dev = standard
deviation, % = percentage.
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increasing age. Sedentary and light activities were lowest in the youngest age
group and increased with increasing age (table 8).
Absolute risk A had the highest correlations with total activity counts (TAC)
(r =-0.40), time in 5 minute bouts of moderate activity (Tmod) (r = -0.34) and time
in 5 minute bouts of vigorous activity (Tvig) (r = -0.35). When observing intensity
of PA in individual minutes accumulated for totals of 5 minutes up to 90 minutes
(hct5 to hct 90), the highest correlations were found with Absolute risk A at r
values ranging from r = -0.40 to r = -0.41 (table 9). Once it was established that
absolute risk A had the highest correlations with activity counts, a stepwise
regression revealed that hct30 provided the best fit regression line with r = -0.41
and the standard error of the estimate (SEE) at 0.55.
When multiple regression analysis of CV risk was performed with both
duration component and an intensity component, hct30 and Tmod provided the
best fit line with r = - 0.422 and SEE = 0.55. The regression of hct5 and Tmod
with CV risk resulted in r = 0.404 and SEE = 0.55. The multiple regression
equation that provides a best fit line for CV risk for all subjects is CV risk = 4.298
+ 0.006 (age) - 0.00009 (hct30), r = -0.434.
When each gender was analyzed separately, the best fit regression line of
absolute risk A for men was with total daily activity and age (r = - 0.53, SEE
=0.58), [CV risk = 4.84 + 0.0026 (age) – 0.000002 (TDC)]. For women, hct30 and
age had the best fit (r = -0.44, SEE = 0.50), [CV risk = 4.115 + 0.0079 (age) 0.000068 (hct30)]. When analyzed by age group, the best fit line for group 1
(ages 18-24) was with hct5, r = -0.45, SEE = 0.40 and the best fit line for group 2
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Table 8
Percent Time in Each Activity Intensity By Age and Gender
Vigorous

Moderate

Light

Sedentary

Sedentary
and Light

All

0.6%

5.3%

20.2%

73.9%

94.1%

Younger

0.9%

6.1%

19.3%

73.7%

93.0%

Middle

0.5%

4.7%

20.3%

74.6%

94.9%

Older

0.3%

5.0%

21.3%

73.5%

94.7%

Males

0.5%

6.0%

19.8%

73.7%

93.5%

Females

0.6%

4.9%

20.4%

74.0%

94.5%

Table 8: Comparison by age category and gender of percentage of day spent in
each level of activity intensity. % = percentage.
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Table 9
Correlations of CV Risk Equations with Minutes of Activity Intensity
average average average average average average average
5
10
20
30
45
60
90
CV risk
minutes
minutes
minutes
minutes
minutes
minutes
minutes
equation
highest highest highest highest highest highest highest
activity activity activity activity activity activity activity
A

-0.40

-0.41

-0.41

-0.41

-0.41

-0.41

-0.41

B

-0.33

-0.35

-0.35

-0.35

-0.35

-0.35

-0.35

C

-0.33

-0.35

-0.36

-0.36

-0.36

-0.35

-0.36

Table 9: Correlations of each of the cardiovascular risk equations with multiple
levels of physical activity intensity. CV = cardiovascular. All values listed in the
table were significant at p < 0.05 level.
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(ages 25-44) was with total counts, r = - 0.41 and the SEE = 0.71. A significant
regression line was not found for Group 3 (ages 45-65) but total counts provided
the best fit line at r = -0.33, SEE =0.53, p = 0.06.
If the subjects were further divided into age categories by gender, the type
of PA best correlated with CV risk in younger males was with the highest
intensity 5 minutes (r = -0.49, SEE = 0.41) and in younger females was with the
highest intensity 30 minutes (r = -0.50, SEE = 0.38). In both males and females
aged 25 to 45 as well as males from 45 to 65, the best correlations were found
with total counts per day (r = -0.63, r = -0.37 and r = -0.56 respectively). For
females aged 45 to 65, there were no significant correlations found between any
PA and CV risk.
Discussion
The results of this study affirm the relationship between PA and CV risk
factors. Unique to this study is the characterization of the intensity and duration
of PA in a way that was not previously possible. The introduction of
accelerometers into PA measurement has enabled further exploration of activity
intensity and duration specifics. It is now possible to examine and evaluate
differences in activity patterns and assess the patterns of PA that best relate to
the prevention of chronic diseases.
Previous to the use of accelerometers, the standards for measurement of
daily PA included self-report observations and cardiorespiratory fitness.256 The
current recommendations are based primarily on research that used either
fitness level or self-report to measure PA.2 It is well established that self-reported
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Table 10
Correlations of CV risk A with PA by age & gender
Males

Females

18 to 25

25 to 45

45 to 65

18 to 25

25 to 45

45 to 65

Total counts
per day

0.395

0.631*

0.560*

0.343

0.369*

0.183

hct 5

0.488*

0.491

0.379

0.463

0.359

0.167

hct 30

0.418

0.517

0.513

0.500*

0.343

0.189*

Table 10: Highest correlations between cardiovascular risk A and accelerometer
activity counts by gender and age category. CV = cardiovascular, PA = physical
activity, hct 5 = highest intensity 5 minutes, hct 30 = highest intensity 30 minutes.
* indicates highest r values for each group.
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PA has an inverse relationship with CVD risk and that the relationship between
fitness and CVD health is even stronger than that of self-reported PA.2, 256
However, the measurement of fitness (VO2max) has a large genetic
component 257, 258 and does not include the specifics of habitual activity such as
total daily activity or time spent in moderate and vigorous activity. Because these
measurement methods do not directly measure PA, doubt has remained as to
the optimal parameters (frequency, intensity and duration) of exercise.256 Using
accelerometers, it is possible to objectively assess the quality and quantity of PA
as it is accumulated throughout the day. Previous findings have been confirmed
and further information has been obtained regarding intensity and duration.
A cross-section of an apparently healthy population (table 6) was
sampled. Of the participants in our study, 67% met or exceeded 30 minutes of
moderate (or higher) daily PA 5 of 7 days per week and 45% met these
guidelines 6 of the 7 days per week. Depending on the definition of “most days of
the week” these numbers are different than the survey data previously reported
by the Centers for Disease Control (CDC) in which 60 % of the adult population
was not regularly active 5 or more days per week.2 If regularly active is defined
as 6 or more days a week, our numbers are closer to those reported by the CDC.
Additionally, since subjects were recruited by students enrolled in a college upper
division exercise physiology class, our sample may be more active than the
general population.
The PA patterns of our sample are comparable to that of other studies
using accelerometers. In this investigation, 76.5 minutes per day were spent in
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moderate activity while only 8.5 minutes per day were spent in vigorous activities.
These results are similar to those observed by Buchowski et al. in a study of
healthy adults’ in a southern US city. Approximately 1 hour per day was spent in
moderate activities and less than 10 minutes was accumulated in vigorous
activity.249 Non-sedentary minutes totaled 985 per day for men and 935 per day
for women. Matthews et al. in a study of daily PA variance of healthy adults,
observed time in non-sedentary activity was similar to the current study with 912
minutes for men and 896 for women.140
PA and CVD risk
Correlational values for physical activity and CVD in the current study
ranged from r = - 0.398 to -0.422 for all subjects. This is a clinically important
finding. Previous researchers report correlations between physical activity and
heart disease to be r = – 0.258239 and between physical activity and individual
risk factors of blood pressure, BMI and HDL to range from r = 0.09 to 0.14.259
Several quantification methods for PA intensity and duration were
modeled. Total activity counts supplies information on the total amount of daily
activity regardless of intensity. The time in moderate and vigorous categories
allow assessment of duration at particular intensity levels. Evaluation of individual
minutes of highest intensity, accumulated for periods of 5 to 90 minutes, allows
assessment of short-term, high-intensity activity.
Most previously reported data demonstrate that duration of moderate or
above PA intensities is inversely related to CVD.56 Additionally, higher fitness
levels (VO2max) are related to decreased CV risk.2, 124 In the current study, the
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30 individual minutes of highest intensity accumulated (hct30) provided the best
relationship with CVD risk (r = -0.41) for all subjects. Time spent in moderate and
vigorous activity was significantly and inversely related to CV risk (Tmod: r = 0.34, Tvig: r = -0.35) however, both total activity counts (TAC) and the 5
individual minutes of highest intensity accumulated (hct5) were better associated
with decreased CV risk (r = - 0.40). In addition, using both duration (Tmod) and
intensity (hct 30) components in the prediction equations did not significantly
improve the r values over using an intensity component alone.
Intensity levels of activity were converted into MET levels using
established prediction equations.255 The levels of intensity achieved in the hct5
minutes ranged between 7 and 10 METs. This intensity corresponds to activities
such as jogging, jumping rope, playing basketball, racquetball, soccer or singles
tennis, backpacking or walking upstairs, walking 5 mph on a level surface, lap
swimming, cross country skiing, and snowshoeing. The levels of intensity
achieved in hct30 were between 5 and 9 METs. Activities in this range include
cycling >10mph, low impact aerobics, dancing (such as square, line country,
swing, polka), walking greater than 4.0 mph (15 min/mile), swimming, and
walking upstairs.
At higher intensities, duration may not be as important as originally
thought. Instead, as Yu et al. suggest, attaining higher intensity levels for shorter
time periods may be more beneficial for health benefits, particularly at younger
ages.187 As noted in our study, reaching higher intensity levels for 1 minute
periods accumulated for at least 5 minutes a day appears to be better related to
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lower risk of CVD than longer durations of moderate or vigorous activity per day
(table 10). This would be consistent with studies using fitness as a measure of
PA124, 129 if VO2max is better related to the highest habitual intensity levels
obtained than accumulated time in moderate activity.
The results of the current study suggest that to reduce risk for CVD in
apparently healthy individuals, longer durations of moderate or vigorous activity
are important, but that 5 minutes of high intensity activity is better related to lower
levels of CVD risk factors. This relationship is maintained up to the 90 individual
minutes of highest intensity (table 8). The results of this study lend support to the
need to incorporate PA throughout the day and the importance of including short
periods of higher intensity activity. Furthermore, our data give further guidance
about the required intensity and duration necessary to promote reduction of CV
risk. As little as 5 individual minutes of higher intensity activity along with
accumulation of moderate activity throughout the day may provide the best
combination of PA related to inverse CV risk.
Accelerometers have been proven valid and reliable instruments to
determine habitual PA and to measure energy expenditure in ambulatory
individuals. The accelerometer appears to overcome the subjective limitations of
PA recall and additionally provides information on duration and intensity of PA
that cannot be provided by other instruments such as pedometers or fitness
testing. Using accelerometry to understand the relationship between both
intensity and duration of PA with CV risk, it may become possible to improve both
general and individual PA recommendations.
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Limitations of the study
Accelerometers are highly correlated to walking and jogging activities (r =
0.89-0.99) 133, 138, 143 however there are limitations regarding type of activity being
performed. Accelerometers placed at the hip are unable to detect increases in
energy costs associated with upper body movement, changes in surface or
terrain (walking, running or hiking uphill), or activities involving external work.260262

In these activities, activity would be underestimated. Also, an attempt was

made to obtain a cross section of the local population however, because it was a
sample of convenience, it may not be representative of the general population.
Conclusions
From these results, we conclude that the greater the volume of activity
accumulated, the lower the CVD risk. However, the highest PA intensity levels
achieved for durations as short as 1 minute, 5 times per day were more strongly
associated with lower risk, particularly in younger individuals. These are clinically
important findings because the correlational values obtained in this study are
higher than those from previous studies and because additional information on
the relationship between physical activity and CV risk has been uncovered.
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CHAPTER 5
EXAMINING HABITUAL PHYSICAL ACTIVITY AND CARDIOVASCULAR
DISEASE RISK FACTORS IN STROKE SURVIVORS

Abstract
Purpose: The purposes of this study are to: 1. Compare the measurable
risk factors for CVD and physical activity level between individuals after stroke
and age-gender matched able-bodied controls. 2. Establish the relative intensity
and duration of physical activity in a sample of stroke survivors. Managing
cardiovascular disease (CVD) risk factors and increasing habitual physical
activity (PA) have been shown to decrease risk of cardiovascular (CV) events in
healthy individuals and those with coronary heart disease. Controlling CVD risk
factors may also lower risk of CV events in stroke survivors. Because no studies
have examined CVD risk factor levels in stroke survivors, it is uncertain how
effectively CVD risk factors are managed in this population. Intensity and
duration of PA are the basis of the current habitual PA recommendations from
the American College of Sports Medicine. Neurological impairments from stroke
decrease energy efficiency of movements thereby increasing energy costs of
movement. As a result, a higher intensity of PA is required for mobility and
routine daily activities. If stroke survivors work harder than individuals without
impairment to perform the same task, then fitness levels should be higher in
stroke survivors unless other parameters of physical activity differ. Most of the
data available on habitual PA in stroke survivors are collected through
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cardiorespiratory fitness testing. Cardiorespiratory fitness is strongly associated
with health benefits and directly related to habitual physical activity but does not
provide the specifics of habitual PA such as intensity and duration. Observation
of the intensity and duration of habitual activity would allow comparison of the
relative intensities of physical activity in stroke survivors to the apparently healthy
population. Methods: Complete data sets were collected on 16 subjects, 7 men
and 1 woman each in the experimental and age-matched control groups.
Experimental group participants had to be status post ischemic stroke for at least
3 months, independent ambulators, with or without an assistive device and in
good general health (medically stable). Resting blood pressure, height, weight
and waist girth were measured. Fasting blood samples was analyzed for total
cholesterol (TC), low density lipoprotein cholesterol (LDL), high density
lipoprotein cholesterol (HDL), triglycerides, C-reactive protein and glycosylated
hemoglobin (HbA1c). Habitual PA was assessed for 7 days with an
accelerometer. Oxygen consumption and accelerometer data were recorded
during a 6 minute walk test. From the 6 minute walk data, step counts were
calculated for PA intensities of 3 and 6 METs. Means and standard deviations of
descriptive variables and dependent variables were calculated within each group.
T-tests analyses determined group differences comparing scores of stroke
survivors to age matched controls. All significance levels were set at p < 0.05.
Results: Elevated levels of systolic blood pressure (136.6 + 11.3 mmHg) and BMI
(30.6 + 3.1 kg/m2) were observed in the stroke group. Significant differences
between the stroke and control groups were found in body mass index (CI: 1.05
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to 7.82 kg/m2) and systolic blood pressure (CI: 0.76 to 26.79 mmHg). No
significant differences were found in diastolic blood pressure, waist girth, HDL,
total cholesterol and HbA1c. During the 6 min walk, PA intensity was significantly
lower in the stroke group (4.48 + 1.08 METs) than the control group (7.00 + 2.23
METs, CI: -4.28 to -0.77 ml/kg/min). Total activity of the stroke group was 34%
lower than the control group (CI: -222,283 to -25,198 counts). Daily time in
moderate activity and above was 15.26 minutes for the stroke group and 32.36
minutes for the control group. Physical activity of the stroke group was only 51%
of the current national physical activity recommendations of 30 minutes of
moderate activity most days of the week. Conclusions: Risk of CV events was
elevated in this sample of stroke survivors. Three out of 6 of the modifiable risk
factors for CVD were present, blood pressure, obesity and sedentary lifestyle.
Physical activity in this group of stroke survivors was well below the
recommended intensity and duration for risk reduction of chronic disease,
premature mortality and CV events. Neurological limitations of stroke promote a
sedentary lifestyle. Cardiorespiratory fitness may need to be addressed
separately from functional assessments of activities of daily living in the
rehabilitation of stroke survivors. Physical limitations must be overcome to
provide the best outcome for these individuals and improve quality of life.
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Introduction
Cardiovascular (CV) events such as recurrent stroke and myocardial
infarction are the leading causes of death in stroke survivors.263, 264 Up to 75% of
stroke survivors have cardiovascular disease (CVD).263, 265, 266 Managing CVD
risk factors such as hypertension, dyslipidemia, diabetes mellitus, and obesity
along with increasing habitual physical activity have been shown to decrease risk
of CV events in healthy individuals and those with coronary heart disease CAD.59

Controlling CVD risk factors may also lower risk of CV events in stroke

survivors. Yet CVD and its risk factors remain understudied in this population.267
Although data exist on levels of individual CVD risk factors in stroke survivors, no
studies are known to this author that compare CVD risk factor levels in stroke
survivors to healthy age-matched individuals. Therefore, it is uncertain how
effectively CVD risk factors are managed in stroke survivors.
In the able-bodied, physical activity has been shown to be effective in
controlling many individual CVD risk factors such as blood pressure, cholesterol,
body mass index (BMI), and blood sugar.5, 9, 52, 164 It is likely that the health
benefits of habitual physical activity in stroke survivors are similar to that of
apparently healthy individuals.4 Until recently, little attention has been paid to
habitual activity in stroke rehabilitation. Information provided by self-report
questionnaires indicate that stroke survivors spend the majority of their day in
sedentary activities.268 Other available information on physical activity in stroke
survivors has been obtained through peak fitness testing (VO2max or VO2peak).
Two separate studies published in 2005 reported peak fitness to be significantly
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lower in a sample of subjects one year after a stroke event than in age matched
controls.269, 270
Although peak fitness testing provides information on habitual daily
activity, it is generally not recommended in this population due to the increased
risk of CV events when exercising at near maximal levels.223 Submaximal fitness
testing is often used as an alternative to provide estimates of VO2max using
prediction equations. An example of a submaximal test commonly used in stroke
survivors is the 6 minute walk.223
Most individuals regain independence in household ambulation after
experiencing a stroke, however the majority do not regain sufficient aerobic
capacity to function in the community and work outside the home.263, 271 Residual
neurological impairments often affect mobility and the ability to perform routine
daily activities. These neurological impairments can decrease energy efficiency
of movements thereby increasing energy costs of movement. As a result, a
higher relative intensity is generally required for mobility and routine daily
activities. If stroke survivors work harder than individuals without impairment to
perform the same task then fitness levels should be higher in stroke survivors
unless other parameters of physical activity differ.
Whether submaximal or maximal, fitness testing represents the potential
for physical activity and does not provide specifics of daily physical activity such
as intensity and duration. Using a device like an accelerometer to monitor
physical activity can provide objective information on intensity and duration of
habitual physical activity with minimal lifestyle intrusion. Observation of the
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intensity and duration of habitual activity would allow comparison of the relative
intensities of physical activity in stroke survivors to the apparently healthy
population. Using the information on habitual activity provided by accelerometers
will also allow closer examination of the relationship between habitual physical
activity and other CVD risk factors in this population. If the energy cost of
physical activity is higher, does the relationship between physical activity and
CVD risk factors also change?
The purposes of this study are to: 1. Establish the relative intensity and
duration of physical activity in a sample of stroke survivors. 2. Compare the
measurable risk factors for CVD and physical activity level between individuals
after stroke and age-gender matched able-bodied controls.
Methods
Informed written consent was obtained from all subjects and all
procedures were approved by The University of Montana Institutional Review
Board for Use of Human Subjects and conformed to the Declaration of Helsinki.
Participants were recruited by convenience sampling through word of mouth and
informational flyers. To be eligible for this study, experimental group participants
had to be independent ambulators, with or without an assistive device, in good
general health (medically stable) and status post ischemic stroke for at least 3
months. Members of the control group were recruited to match age and gender
of those in experimental group. Exclusion criteria for both groups included: recent
infection or surgery within the past 3 months, uncontrolled or poorly controlled
hypertension, and previous myocardial infarction, hemorrhagic stroke or
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diagnosed cardiomyopathy. Complete data sets were collected on 16 subjects,
with 7 men and 1 woman each in the control and experimental groups.
Once recruited, the participants were asked to read and sign the consent
form. Participants then completed the physical activity readiness questionnaire
(PAR-Q) form272 and a medical history form to determine if they met the criteria
of the study and to provide a list of medications. Once these forms were
completed, a heart rate monitor was placed around the torso and participants
completed the Physical Activity Scale for Individuals with Disabilities
(PASIPD).273 Resting blood pressure was taken by a trained technician using a
sphygnomometer and standard protocol.222 Pulse was monitored throughout the
remainder of the seated period and the lowest observed number recorded. Then
height, weight and waist girth were measured and recorded per protocol.223
Activity Monitors
Habitual PA was assessed with the Actical accelerometer (Mini Mitter,
Bend, Oregon). After obtaining height and weight measurements, participants
were fitted with accelerometers on the non-paretic (or dominant) hip and worn for
a total of 7 days including a weekend period. Placing a single device on the hip
or lower back is recommended.142 The monitors were secured at the hip with
TegadermTM (3MTM, St. Paul, Minnesota) to ensure proper placement of the
monitors. The participants wore the devices for 7 days and were able to shower
and swim without restriction. Previous research has shown that in adults, a
minimum of 3 to 5 days of monitoring is optimal to determine activity patterns.140,
142

The period of 7 days was chosen to ensure inclusion of both weekend days
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and weekdays. Log sheets were provided to record any activities such as riding
or driving on a bumpy road that might overestimate activity and any times where
they neglected to wear the device.
The Actical activity monitors are small (2.8 x 2.7x1.0 cm3), lightweight
(17g) units that have a primary plane of detection but are sensitive to all three
planes of motion.248 The Actical is a piezo-electric accelerometer with a range of
0.5 to 2G and frequency of 0.35 to 3.5 Hz. The Actical samples acceleration at a
rate of 32 Hz and integrates this over the user-defined epoch.248 In this study, the
epoch was set at 15 seconds, comprising an integral of 5760 measurements for
each day.
The 6-minute walk
The 6-minute walk took place using an accelerometer and the portable
metabolic system on a 200 ft rectangular loop. The participants were familiarized
with the Borg 6-20 Rate of Perceived Exertion (RPE) scale, portable metabolic
cart (VO 2000, Medgraphics, Minneapolis, Minnesota) and the Actical™
accelerometer. Heart rate was monitored via a polar heart rate monitor and
activity was monitored by accelerometers on the non-paretic (or dominant) hip.
Energy expenditure was assessed using the VO2000 portable metabolic system,
a 1.5 lb device worn in a small back pack. The VO 2000 was calibrated before
each test. The participant was asked to walk for 6 minutes around the designated
loop and to cover as much distance as they comfortably could in that time period.
During the testing, the participant used any assistive device normally used for
walking and continuous monitoring of oxygen consumption and CO2 production
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was performed. Heart rate was recorded every lap. Distance was measured to
the nearest meter at the completion of the test.
Timed up and go testing
Participants were asked to stand up from a chair, walk 3 meters, turn
around, return to the chair, and sit down. Time taken to complete this task was
measured by a stopwatch and this task was repeated 3 times with the shortest
recorded time used for data analysis. During the test, accelerometers on the nonparetic (or dominant) hip monitored movement and participants were permitted to
use any assistive device normally used for walking.
A blood sample was collected from the participants within 2 weeks of the
testing session detailed above. Participants were asked to fast for 12 hours prior
to blood sample collection. Two 12ml vials of venous blood were drawn and
analyzed at a hospital laboratory for lipids [total cholesterol (TC), low density
lipoprotein cholesterol (LDL), high density lipoprotein (HDL), triglycerides], high
sensitivity C-reactive protein (CRP) and glycosylated hemoglobin (HbA1c) to
measure average blood glucose. Samples were analyzed for CRP, HbA1c and
lipids enzymatically using an automated clinical chemistry analyzer (RocheHitachi P-module, Indianapolis, IN) with estimation calculation of LDL cholesterol
using the Friedewald equation.79
Data analysis
As the activity monitors were collected, the data was downloaded into a
computer file using the Minimiter software. Using the activity log sheets
completed by the participant, data for time periods that might overestimate
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activity such as riding or driving on a bumpy road were eliminated. Also, all
Actical files were screened for periods of zero activity. If the Actical was not worn,
per report on the activity log sheet, this data was removed from the analysis.
Because there are no published data available that relate oxygen
consumption with activity counts in stroke survivors, analysis of this relationship
was individualized for each subject. Ventilation and activity counts were
concurrently recorded during the 6 minute walk. Using data from the last 3 to 4
minutes of the 6 minute walk when oxygen consumption was steady, the counts
per minute were averaged. Average metabolic equivalent (MET) level during this
time period was also calculated. From this information, the numbers of counts
per minute corresponding to 3 and 6 METs were calculated for each individual
assuming a linear relationship between oxygen consumption and step count.
These MET levels were selected because they are the established cutoffs
between light, moderate and vigorous activity.252 From these data, time in 3
activity intensity levels (< moderate, moderate, and vigorous) was determined for
each individual during the 7 days of activity monitoring. Because only moderate
intensity and above activity is considered cardioprotective, no attempt was made
to differentiate between sedentary and light activity in this study. Average counts
per day, average counts per minute, time in sedentary and light activity and time
in moderate and above activity were used for statistical analysis. Using average
counts per day quantifies total daily activity while utilizing average counts per
minute allows for determination of activity intensity.
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Statistics
Means and standard deviations of descriptive variables and dependent
variables were calculated within each group. Data analysis was performed both
with all subjects and then with males only. T-tests analyses were used to
determine group differences comparing scores of stroke survivors to age
matched controls. When equal variances could not be assumed (Levine’s test for
equality of variances) the more stringent values were reported. A p value of less
than 0.05 was considered to be statistically significant. SPSS 12.0 (SPSS, Inc.,
Chicago, Illinois) was used for all data analysis.
Results
Complete data sets were obtained for eight subjects, 7 men and 1 woman
in each group, stroke survivors and the control group. Means and standard
deviations of descriptive variables appear in tables 11 through 14. Dependent
variables included body mass index (BMI), waist girth, systolic and diastolic blood
pressure (table 11), total cholesterol, LDL cholesterol, HDL cholesterol, CRP,
blood glucose (HbA1c) (table 12), timed up and go (TUG), the 6 minute walk test
(table 13) and accelerometer data (table 14). Analyzed accelerometer data
included total activity, average intensity, and time in 3 intensities of activity
(sedentary & light, moderate and vigorous).
All subjects
T-test results indicated significant differences between groups in BMI (CI:
1.05 to 7.82 kg/m2), systolic blood pressure (CI: 0.76 to 26.79 mmHg), LDL
cholesterol (CI: -73.68 to -16.46 mg/dl), TUG (CI: 1.06 to 23.07 seconds), 6
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Table 11
Descriptive Statistics and T-test Results
95% Confidence
Interval

Stroke Group

Control Group

Mean

SD

Mean

SD

Lower

Upper

Age (yrs)

63.67

9.03

61.33

8.00

-6.19

10.86

Height (cm)

176.25

9.37

175.97

9.69

-9.24

9.81

Weight (kg)

94.66*

11.24

80.46*

10.93

3.12

25.28

Waist (cm)

105.80

11.61

96.67

9.97

-1.68

19.95

SBP
(mmHg)

138.56*

11.26

124.78*

14.58

0.76

26.79

DBP
(mmHg)

74.00

8.26

81.33

7.55

-15.24

0.57

BMI (kg/m2)

30.50*

3.08

26.07*

3.66

1.05

7.82

Table 11: T-test results for descriptive variables between experimental (stroke)
group and control group displaying means, standard deviations and confidence
intervals. SD = standard deviation, yrs = years, cm = centimeters, kg = kilograms,
SBP = systolic blood pressure, mmHg = pressure in millimeters of mercury, DBP
= diastolic blood pressure, BMI = body mass index, m = meters, * indicates
statistical significance at p < 0.05.
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Table 12
T-test Results for Blood Sample Variables
95% Confidence
Interval

Stroke Group

Control Group

Mean

SD

Mean

SD

Lower

Upper

TG (mg/dL)

208.25

137.10

112.11

69.17

-23.34

215.62

TC (mg/dL)

175.38

20.36

205.11

46.55

-67.29

7.82

HDL
(mg/dL)

55.13

11.12

54.22

14.51

-12.60

14.40

LDL (mg/dL)

83.38*

16.86

128.44*

34.38

-73.68

-16.46

HbA1c (%)

5.64

0.44

5.42

0.20

-0.13

0.56

CRP
(mg/dL)

0.33

0.36

0.09

0.07

-0.02

0.50

Table 12: T-test results for blood sample variables between experimental (stroke)
group and control group displaying means, standard deviations and confidence
intervals. SD = standard deviation, TG = triglyceride, mg = milligrams, dL=
deciliter, TC = total cholesterol, HDL = high density lipoprotein, LDL = low density
lipoprotein, HbA1c = glycosylated hemoglobin, % = percentage, CRP = Creactive protein, * indicates statistical significance at p < 0.05.
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minute walk distance (CI: -1,552 to -597.12 feet) and MET level during 6 min
walk (CI: -4.28 to -0.77 ml/kg/min). With the accelerometer data, significant
differences were found in average counts per day (CI: -222,283 to -25,198
counts), average counts per minute (CI: -156.77 to -18.11 counts) and minutes
per day spent in sedentary and light activity (CI: 11.65 to 77.25 minutes). Of note,
differences in the time spent in moderate and above activity approached
significance at p = 0.06. No significant differences were found in diastolic blood
pressure, waist girth, HDL, total cholesterol and HbA1c.
Males only
Significant differences between the group with stroke and control group
were found in BMI (CI: 0.20 to 7.50 kg/m2), systolic blood pressure (CI: 0.05 to
27.95 mmHg), LDL cholesterol (CI: -64.47 to -19.70 mg/dl), TUG (CI: 0.03 to
25.39 seconds), 6 minute walk distance (CI: -1601.34 to -500.54 feet) and MET
level (CI: -4.11 to -0.28 ml/kg/min). Additional significant differences were found
in C-reactive protein levels (CI: 0.01 to 0.27 mg/dl) and time in moderate and
above activity (CI: -47.46 to -1.68). With the accelerometer data, significant
differences were found in average counts per day (CI: -224,388 to -23,093
counts), average counts per minute (CI: -158.17 to -16.71 counts) and minutes
per day spent in sedentary and light activity (CI: 11.65 to 77.25 minutes). Also of
note, differences in waist circumference approached significance at p = 0.06 and,
because equal variance could not be assumed, triglycerides levels were not
significantly different between groups (p = 0.051). No significant differences were
found in diastolic blood pressure, waist girth, HDL, total cholesterol and HbA1c.
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Table 13
T-test Results for Functional Tests
95% Confidence
Interval

Stroke Group

Control Group

Mean

SD

Mean

SD

Lower

Upper

Best TUG
(seconds)

17.47*

14.32

5.41*

0.46

1.06

23.07

6 min
distance

1091.28*

606.64

2165.67*

208.07

-1,552

-597.12

6 min METs

4.47*

1.08

7.00*

2.23

-4.28

-0.77

Table 13: T-test results for functional tests between experimental (stroke) group
and control group displaying means, standard deviations and confidence
intervals. SD = standard deviation, TUG = timed up and go, 6 min distance =
distance achieved in 6 minute walk test, 6 min METs = average energy
expenditure during last half of 6 minute walk test, * indicates statistical
significance at p < 0.05.
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Table 14
T-test Results for Accelerometer Data
95% Confidence
Interval

Stroke Group

Control Group

Mean

SD

Mean

SD

Lower

Upper

65,057*

69,191

188,798*

121,077

-222,283

-25,198

46.16*

49.34

133.59*

84.80

-156.77

-18.11

Min/day
Sed & Light

1,429*

14.58

1,385*

41.64

11.65

77.25

Min/day
Moderate

14.27

13.08

30.35

28.47

-38.21

6.07

Min/day
Vigorous

0.99

1.57

2.02

2.31

-3.00

0.95

Min/day in
Moderate &
above

15.27

13.45

36.43

28.31

-43.62

1.3

Total
Activity
(cts/day)
Average
Intensity
(cts per
min)

Table 14: T-test results for accelerometer data between experimental (stroke)
group and control group displaying means, standard deviations and confidence
intervals. SD = standard deviation, Total activity = average number of counts per
day for the 7 days, Average intensity = average daily counts per minute, cts =
counts, min = minute, Min/day Sed & Light = total minutes per day spent in
sedentary and light intensity activities, Min/day Moderate = total minutes per day
spent in moderate intensity activities, Min/day Vigorous = total minutes per day
spent in vigorous intensity activities. Min/day in moderate and above = total
minutes per day spent in both moderate and vigorous intensity activities,
* indicates statistical significance at p < 0.05.

116

Discussion
Cardiovascular Disease Risk Factors: Although the risk of CV events such
as myocardial infarction (MI) or recurrent stroke is elevated in stroke survivors,
there are few data on CVD risk factors levels in this population. It is important to
determine baseline levels of CVD risk factors in stroke survivors in order to effect
changes in risk of CV events. Systolic blood pressure was significantly higher in
the stroke group than in the control group. The mean systolic blood pressure for
the stroke group was 136.6 mmHg which is classified as pre-hypertension. By
comparison, those in the control group had a mean systolic pressure of 124.8
mmHg, in the high normal range. Seventy five percent of the stroke group and
50% of the control group were taking anti-hypertensive medication.
Researchers have observed blood pressure control to be worse in stroke
survivors than those suffering a myocardial infarction274 even though blood
pressure control is essential for prevention of CV events.275 It is essential to
maintain stringent control of blood pressure, particularly systolic. The risk of
stroke and CVD associated with increasing systolic blood pressure is evident
across the entire range of systolic blood pressure, independent of the level of
diastolic blood pressure.276-279 Even small reductions in blood pressure decrease
risk of stroke. Differences in blood pressure of 5, 7.5, and 10 mm Hg were
associated with reductions in stroke incidence of 34%, 46%, and 56%
respectively.17 The 11.8 mmHg difference in systolic blood pressure between the
stroke and control groups in the current study is clinically important and indicates
that these individuals continue to be at greater CVD risk.
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Body mass index was also significantly higher in the stroke group than in
the control group. The mean BMI was 30.6 kg/m2 in the stroke group with all
subjects in either the overweight or obese range. Mean BMI in the control group
was 26.07 kg/m2. Long term risk of CVD increases significantly with increasing
levels of overweight and obesity.280 The higher the BMI, the greater the
prevalence of myocardial infarction and stroke.281-283 Excess weight is
associated with an increased risk of ischemic stroke independent of diabetes and
other metabolic syndrome components.284 Each 2 kg/m2 increase in baseline
BMI is associated with a 15.4% increase in relative risk of CHD and an 18.8%
increase in relative risk of ischemic stroke. Conversely, reduction of BMI to under
24 might prevent the incidence of CHD by 11% and that of stroke by 15% for
men, and 22% of both diseases for women.282 In the current study, the higher
BMI values found in the stroke group indicate increased CVD risk.
In males, CRP values were higher in the stroke group than the control
group (0.21 mg/dL versus 0.07 mg/dL). Normal concentration levels in the
plasma are less than 0.5 mg/L or 0.05 mg/dL.79 Cardiovascular risk levels are
stratified into low, moderate, and high corresponding to CRP levels of <0.1, 0.1 to
0.3, and > 0.3 mg/dL.102 Levels of CRP can assist with risk prediction of cardiac
events in healthy individuals77, 89, 90, 93 and after an ischemic event.285 In previous
studies, CRP was the single strongest predictor of CV event risk80 even after
controlling for other Framingham risk scores.73 C-reactive protein level is also a
risk predictor for stroke73, 286-288 and recurrent ischemic stroke.289-291 By
controlling CVD risk factors, CRP levels may also be lowered. Obesity, blood
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pressure, diabetes and smoking were all positively associated with levels of
inflammation as measured by CRP.57 Increases in physical activity and
decreases in blood pressure have been inversely related to CRP levels.292
Values below 0.3 mg/dL are considered to be useful in prediction of CV risk. The
findings of the current study are clinically important and consistent with the
literature on CRP indicating the individuals in the stroke group may be at higher
risk for CV events.
Differences in LDL cholesterol levels were also observed. Although LDL
cholesterol levels were significantly higher in the control subjects, the levels were
less than what is considered elevated (> 130 mg/dl).293 Seventy five percent of
the participants in the stroke group (6 of 8) were on medications for lipid
lowering. This may indicate that cholesterol is being managed effectively in the
stroke survivors. Only 1 of 8 participants in the control group was being managed
with medications for dyslipidemia. Medical management of cholesterol levels less
than 130 mg/dL is not recommended for those not at high CVD risk. 223, 293
Blood sugar, diastolic blood pressure and lipid levels were within normal
limits for the stroke group however, elevated levels of systolic blood pressure and
BMI were observed in all subjects and CRP levels were significantly higher than
the control group in males. Hypertension, obesity and low grade inflammation
have been related to increased risk for CV events. From these observations, this
sample of stroke survivors presents with a higher CVD risk than the control group
even without considering the additional risk from having a history of a CV event.
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Daily Physical Activity
The American College of Sports Medicine and Center for Disease Control
recommend at least 30 minutes of accumulated moderate activity most days of
the week for reducing CVD risk.56 Habitual physical activity is important in
moderating CVD risk factors. In apparently healthy individuals, routine physical
activity decreases cardiovascular disease (CVD),4, 45 lowers blood pressure5-9
lowers body fat,5, 9 and decreases systemic inflammation.47-49 Although physical
activity assessments have previously been made in stroke survivors, until
recently it was difficult to objectively measure intensity and duration of physical
activity.
Habitual activity levels were significantly less in the stroke group than in
the age matched control group. Total activity of the stroke group was 34% lower
than the control group as measured by counts per day of 65,057 versus 188,798
respectively. Intensity of physical activity was also lower in the stroke group.
Average counts per minute differed by 87 counts/min with the stroke group
averaging 46.16 counts per minute and the control group averaging 133.59
counts per minute. Time in moderate activity and above was 15.26 minutes for
the stroke group versus 32.36 minutes for the control group. The time stroke
survivors spent in moderate and above activity was only 42% of the control
group. Michael and Macko recently observed steps per day in stroke survivors to
be approximately 35% of sedentary adults.294 The PA in the stroke group was
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only 51% of the current national physical activity recommendations of 30 minutes
moderate activity most days of the week.56
Following completion of rehabilitation, stroke survivors often adopt a
sedentary lifestyle.295, 296 Average time in sedentary activities or sleeping was 17
hours per day with 1 of every 6 individuals sedentary or sleeping for all 24
hours.268 From these data, it is clear that stroke survivors are habitually less
active than their age-matched counterparts. By remaining sedentary,
cardiovascular fitness declines, eventually causing further loss of functional
abilities. Without ample daily activity, risk of CVD is increased. Emphasis on the
importance of increasing physical activity is vital to assist in controlling future risk
of CV events. The sample of stroke survivors in the current study exhibited
habitual activity consistent with findings of previous studies and well below the
amount considered to be cardioprotective in healthy adults. Both duration and
intensity of physical activity was far less in the stroke group than that of the
control group and well below the physical activity recommended by the ACSM for
reduction of health risks.223, 297, 298
Functional Assessments
The results of both the TUG and 6 minute walk are consistent with other
studies of stroke survivors. Mean TUG times were 17.5 + 14.3 seconds for the
stroke survivors. This is 3.2 times slower than the age matched group. Other
researchers have reported average TUG times of 13.7 to 25.2 seconds for those
with stroke.299-304 Mean 6 minute walk distance was 332 meters for stroke
survivors, 50% lower than the control group. Six minute walk distances observed
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in previous studies of stroke survivors ranged from 202 to 491 meters.299, 305-311
In 2 separate studies, distances achieved in the 6 minute walk were 40 to 50%
less than expected.308, 312 In the current study, this sample of stroke survivors
appears to be representative of the population because values observed for the
TUG and 6 minute walk are within the observed ranges of previous studies.
Stroke survivors exhibited significantly lower oxygen consumption (VO2)
during the 6 minute walk test than age matched controls. The mean oxygen
consumption observed in the current research was 15.67 ml/kg/min or 4.48
METs, 58.6% of the age and gender matched controls. Oxygen consumption of
stroke survivors ranged from 8.3 to 16.1 ml/kg/min in previous research313-315
with peak oxygen consumption observed to be significantly lower in participants
who had a stroke than in age and gender matched controls.269, 270 Fitness in
those with stroke has been observed to be 40 to 60% of healthy age-matched
population.311, 315-317 Current ACSM recommendations for minimal physical
activity call for 30 minutes of moderate activity most days per week with
moderate activity defined as activity requiring 3 to 6 METs or 10.5 to 21ml/kg/min
of oxygen consumption. The stroke survivors in this study were able to achieve
moderate level activity averaging 4.48 METs in the 6 minute walk test. Therefore
it is possible for stroke survivors to meet current guidelines for physical activity.
At 60 years old, a peak VO2 above 25 ml/kg/min is considered normal for
women and a peak VO2 above 32 ml/kg/min is considered normal for men.252
Although normal peak VO2 values are different in men and women and decrease
with age, the observed VO2 values of stroke survivors are well below the energy
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cost for most ADLs.269 This is an important observation, that many stroke
survivors do not have the fitness required for independent living, even if their
functional ability is present. Furthermore, an exercise capacity of below 21
ml/kg/min or 6 METs is associated with an increase in mortality.269
Performance in the 6 min walk test can be more strongly influenced by
limits to walking speed such as balance.305, 309, 318 Variances in long distance
walking were largely explained by balance for those who walked more slowly and
fitness for those who walk more quickly.319 The neurological impairments caused
by stroke can limit walking speed or distance preventing the cardiovascular
system stress that improves fitness.320 It is likely that in stroke survivors, the
walking speed observed in the 6 minute walk is the maximum speed that the
individual can achieve in that task. In the majority of stroke survivors, walking is
probably the most demanding daily living activity they perform. As a result the
aerobic capacity of stroke survivors is likely similar to the oxygen consumption at
their highest walking speed. For this sample of stroke survivors, oxygen
consumption averaged 15.67 ml/kg/min, well below the 21 ml/kg/min exercise
capacity associated with increased mortality. 269
If the walking speed is limited by balance, fitness may need to be
separately addressed using activities other than independent walking to reach a
sufficient intensity to challenge the cardiorespiratory system. It is possible to
increase cardiovascular capacity of individuals after stroke. Treadmill walking
with body weight support, stationary cycling and stepping exercises have been
successfully utilized to increase endurance and walking efficiency.269, 270, 321
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Conclusions
It is important to uncover the particulars of physical activity to understand
its relationship to CVD risk. Once the relationship is established, it may be
possible to study the effects of increasing activity on CVD risk factors in this
population. With the increased risk of CV events in survivors of stroke or heart
attack, secondary prevention is essential. This is the first study relating multiple
CVD risk factors to physical activity levels in stroke survivors. Three out of 6 of
the modifiable risk factors for CVD were present in this sample of stroke
survivors. Stroke survivors presented with elevated blood pressure, increased
body mass, and a sedentary lifestyle and are already at increased risk due to
history of CVD and age. That means that 5 of 8 risk factors of CVD are present in
these individuals. Higher CRP levels may indicate risk of stroke or myocardial
infarction is further amplified.
It is imperative to control CVD risk factors in stroke survivors. Besides
pharmacological management, increasing habitual activity should be encouraged
whenever possible. The major challenge is that neurological limitations of stroke
and extra effort required for even the most common activities such as walking,
promotes a sedentary lifestyle. Cardiorespiratory fitness may need to be
addressed separately from functional activities of daily living in the rehabilitation
of stroke survivors. Physical limitations must be overcome to provide the best
outcome for these individuals and improve quality of life.
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CHAPTER 6
CONCLUSIONS

The purpose of this collection of studies was to explore the association of
physical activity with CVD and attempt to identify some specifics of this complex
relationship. Current physical activity recommendations call for 30 minutes of
moderate activity most days of the week or 20 minutes of vigorous activity 3 days
per week. From these recommendations it appears as intensity increases,
duration decreases. The activity accumulation intervention provided in the first
study fits within this continuum. Simply by increasing volume of physical activity
through increases in step counts some of the modifiable CVD risk factors were
improved. However, if the intensity or duration were further increased, additional
improvements in CVD risk factors may occur. The activity accumulation
programs were successful in initiating increases in physical activity and positive
changes in CVD risk factors. To successfully provide additional improvements in
risk factors, adding an intensity component may be optimal.
The optimal intensity and duration of physical activity may change as one
ages. In younger adults, total activity amount was inversely related to CVD risk,
however, higher intensity activities accumulated for periods as short as 5 minutes
provided the best correlations with CVD risk scores. As age increases, this
relationship may diminish and total volume of accumulated activity may be more
important. The highest correlations were observed for total activity in adults ages
25 to 45 and it appeared that with a larger sample size, the relationship may
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continue in the 45 to 65 age range. Further investigation into this relationship in
these age ranges may clarify these observations.
In the study of apparently healthy individuals and stroke survivors, the
inverse relationship between CVD risk factors and physical activity appears to be
maintained. Physical activity in the control group was almost double that of the
stroke survivors. Of the modifiable CVD risk factors measured, 3 were present in
stroke survivors while none were observed in the control group. Although the
relative intensity of daily activities in stroke survivors may be much higher than
age matched controls for walking and other activities of daily living, it appears
that this sample did not sustain these intensities for adequate durations to attain
the cardioprotective effects of physical activity. A larger sample size would be
recommended to make further conclusions about these groups.
In this series of studies, the inverse relationship between CVD and
physical activity has been confirmed. Through the use of activity monitors,
additional insight into intensity and duration specifics has been accomplished.
Much has been learned about the relationship between CVD risk and physical
activity. In general, greater volumes of physical activity provide decreased risk
however intensity and duration play important roles in this complex relationship.
There is much more to be revealed about this association through further studies
of specific age groups and of special populations as well as through various
methods of increasing physical activity.
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